As filed with the Securities and Exchange Commission on May 12, 2015
Securities Act Registration No. 333-202459
Investment Company Act Registration No.   811-23035
 
 
 
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM N-2
 
ý Registration Statement under the Securities Act of 1933
ý Pre-Effective Amendment No. 2
¨ Post-Effective Amendment No.
and/or
ý Registration Statement Under the Investment Company Act of 1940
ý Amendment No. 2

The Gabelli Go Anywhere Trust
(Exact Name of Registrant as Specified in Declaration of Trust)
 
One Corporate Center
Rye, New York 10580-1422
(Address of Principal Executive Offices)
 
(800) 422-3554
(Registrant’s Telephone Number, Including Area Code)
 
Agnes Mullady
The Gabelli Go Anywhere Trust
One Corporate Center
Rye, New York 10580-1422
(Name and Address of Agent for Service)
 

Copies to:
 
Andrea R. Mango, Esq.
 
Richard T. Prins, Esq.
 
Thomas A. DeCapo, Esq.
The Gabelli Go Anywhere Trust
One Corporate Center
 
Skadden, Arps, Slate, Meagher &
Flom LLP
 
Skadden, Arps, Slate, Meagher &
Flom LLP
Rye, New York 10580-1422
 
4 Times Square
 
500 Boylston Street
   
New York, New York 10036
 
Boston, Massachusetts 02116

Approximate Date of Proposed Public Offering: As soon as practicable after the effective date of this Registration Statement.  


CALCULATION OF REGISTRATION FEE UNDER THE SECURITIES ACT OF 1933
Title of Securities Being Registered
Amount Being
Registered
Proposed
Maximum
Offering Price
per Unit
Proposed
Maximum
Aggregate
Offering Price
Amount of
Registration
Fee
Common Shares, $0.001 par value (“Common Shares”)
N/A
N/A
$1,000,000(1)
$116.20(2)
Series A Cumulative Puttable and Callable Preferred Shares, par value $0.001 (“Series A Preferred Shares”)
N/A
N/A
$1,000,000(1)
$116.20(2)
Combinations, each consisting of three Common Shares and one Series A Preferred Share
N/A

(1)
 
Estimated solely for purposes of calculating the registration fee pursuant to Rule 457(o)
(2)
 
$116.20 previously paid.



 
 

 


THE REGISTRANT HEREBY AMENDS THIS REGISTRATION STATEMENT ON SUCH DATE OR DATES AS MAY BE NECESSARY TO DELAY ITS EFFECTIVE DATE UNTIL THE REGISTRANT SHALL FILE A FURTHER AMENDMENT WHICH SPECIFICALLY STATES THAT THE REGISTRATION STATEMENT SHALL THEREAFTER BECOME EFFECTIVE IN ACCORDANCE WITH SECTION 8(a) OF THE SECURITIES ACT OF 1933 OR UNTIL THE REGISTRATION STATEMENT SHALL BECOME EFFECTIVE ON SUCH DATES AS THE SECURITIES AND EXCHANGE COMMISSION, ACTING PURSUANT TO SAID SECTION 8(a), MAY DETERMINE.
 
 
 


 
 

 
 
EXPLANATORY NOTE

The Prospectus, in the form filed on April 17, 2015 with Pre-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form N-2, is incorporated by reference.

This Pre-Effective Amendment No. 2 to the Registrant’s Registration Statement is being filed solely for the purpose of filing with the Commission certain of the exhibits set forth in Item 25 to Part C of the Registration Statement.


 
 

 

PART C
 
Other Information
Item 25.      Financial Statements And Exhibits
(1)
 
Financial Statements
     
   
Part A:
     
   
Part B:
     
   
Audited Financial Statements – to be included in SAI by pre-effective amendment
     
   
Report of Independent Registered Public Accounting Firm – to be included in SAI by pre-effective amendment
     
(2)
 
Exhibits
     
(a)
 
(i)
 
Agreement and Declaration of Trust of Registrant(1)
         
   
(ii)
 
Form of Statement of Preferences for Series A Preferred Shares – filed herewith
         
(b)
     
Bylaws of Registrant(1)
         
(c)
     
Not applicable
         
(d)
     
Not applicable
         
(e)
     
Form of Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan of Registrant – filed herewith
         
(f)
     
Not applicable
         
(g)
     
Form of Investment Advisory Agreement between Registrant and Gabelli Funds, LLC – filed herewith
         
(h)
 
(i)
 
Form of Distribution Agreement – filed herewith
         
 
 
(ii)
 
Form of Soliciting Dealer Agreement(2)
         
   
(iii)
 
Form of Information Agent Agreement(2)
         
(i)
     
Not applicable
         
(j)
     
Form of Custodian Agreement(2)
         
(k)
 
(i)
 
Form of Registrar, Transfer Agency and Service Agreement(2)
         
   
(ii)
 
Form of Escrow Agent Agreement(2)
         
   
(iii)
 
Form of Information Agent Agreement(2)
         
(l)
     
Opinion and Consent of Skadden, Arps, Slate, Meagher & Flom LLP – filed herewith
         
(m)
     
Not applicable


 
C-1

 


(n)
     
Consent of Independent Registered Public Accounting Firm Consent(2)
         
(o)
     
Not applicable
         
(p)
     
Initial Subscription Agreement – filed herewith
         
(q)
     
Not applicable
         
(r)
 
(i)
 
Code of Ethics of the Fund and the Adviser – filed herewith
         
 
 
(ii)
 
Joint Code of Ethics for Chief Executive and Senior Financial Officers of the Fund – filed herewith
         
(s)
     
Power of Attorney – filed herewith
 

(1)
 
Previously filed as an exhibit to Pre-Effective Amendment No. 1 to the Registrant’s Registration Statement on Form N-2, as filed with the Securities and Exchange Commission on April 17, 2015 (File Nos. 333- 202459 and 811-23035).
     
(2)
 
To be filed by pre-effective amendment.

Item 26.  Marketing Arrangements
The information contained under the heading “Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan” on page 60 of the Prospectus is incorporated by reference.

Reference is made to the Form of Distribution Agreement and the Form of Soliciting Dealer Agreement for the Registrant’s shares of beneficial interest to be filed with this registration statement by pre-effective amendment.
 
Item 27.  Other Expenses Of Issuance And Distribution
The following table sets forth the estimated expenses to be incurred in connection with the offering described in this Registration Statement:

NYSE listing fee
 
$
   
SEC registration fees
       
FINRA filing fee
       
Printing/engraving expenses
       
Accounting fees
       
Legal fees
       
Transfer Agent fees
       
Blue Sky fees
       
Miscellaneous
       
 Total
 
$
   
 
Item 28.  Persons Controlled By Or Under Common Control With The Registrant
None.
 
Item 29.  Number Of Holders Of Shares
As of May 12, 2015:

Title of Class
 
Number Of Record Holders
Common Shares of Beneficial Interest
 
1
Series A Preferred Shares
 
1
 
Item 30.  Indemnification
 
Article IV of the Registrant’s Agreement and Declaration of Trust provides as follows:
 

 
C-2

 

4.1           No Personal Liability of Shareholders, Trustees, etc.  No Shareholder of the Trust shall be subject in such capacity to any personal liability whatsoever to any Person in connection with Trust Property or the acts, obligations or affairs of the Trust. Shareholders shall have the same limitation of personal liability as is extended to stockholders of a private corporation for profit incorporated under the Delaware General Corporation Law. No Trustee or officer of the Trust shall be subject in such capacity to any personal liability whatsoever to any Person, other than the Trust or its Shareholders, in connection with Trust Property or the affairs of the Trust, save only liability to the Trust or its Shareholders arising from bad faith, willful misfeasance, gross negligence or reckless disregard for his duty to such Person; and, subject to the foregoing exception, all such Persons shall look solely to the Trust Property for satisfaction of claims of any nature arising in connection with the affairs of the Trust. If any Shareholder, Trustee or officer, as such, of the Trust, is made a party to any suit or proceeding to enforce any such liability, subject to the foregoing exception, he shall not, on account thereof, be held to any personal liability.
 
4.2
 
Mandatory Indemnification.
   
(a)
 
The Trust shall indemnify the Trustees and officers of the Trust (each such person being an " indemnitee ") against any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise or as fines and penalties, and reasonable counsel fees reasonably incurred by such indemnitee in connection with the defense or disposition of any action, suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body in which he may be or may have been involved as a party or otherwise (other than, except as authorized by the Trustees, as the plaintiff or complainant) or with which he may be or may have been threatened, while acting in any capacity set forth above in this Section 4.2 by reason of his having acted in any such capacity, except with respect to any matter as to which he shall not have acted in good faith in the reasonable belief that his action was in the best interest of the Trust or, in the case of any criminal proceeding, as to which he shall have had reasonable cause to believe that the conduct was unlawful, provided, however, that no indemnitee shall be indemnified hereunder against any liability to any person or any expense of such indemnitee arising by reason of (i) willful misfeasance, (ii) bad faith, (iii) gross negligence, or (iv) reckless disregard of the duties involved in the conduct of his position (the conduct referred to in such clauses (i) through (iv) being sometimes referred to herein as " disabling conduct "). Notwithstanding the foregoing, with respect to any action, suit or other proceeding voluntarily prosecuted by any indemnitee as plaintiff, indemnification shall be mandatory only if the prosecution of such action, suit or other proceeding by such indemnitee was authorized by a majority of the Trustees.
         
   
(b)
 
Notwithstanding the foregoing, no indemnification shall be made hereunder unless there has been a determination (1) by a final decision on the merits by a court or other body of competent jurisdiction before whom the issue of entitlement to indemnification hereunder was brought that such indemnitee is entitled to indemnification hereunder or, (2) in the absence of such a decision, by (i) a majority vote of a quorum of those Trustees who are neither Interested Persons of the Trust nor parties to the proceeding (" Disinterested Non-Party Trustees "), that the indemnitee is entitled to indemnification hereunder, or (ii) if such quorum is not obtainable or even if obtainable, if such majority so directs, independent legal counsel in a written opinion conclude that the indemnitee should be entitled to indemnification hereunder. All determinations to make advance payments in connection with the expense of defending any proceeding shall be authorized and made in accordance with the immediately succeeding paragraph (c) below.
         
   
(c)
 
The Trust shall make advance payments in connection with the expenses of defending any action with respect to which indemnification might be sought hereunder if the Trust receives a written affirmation by the indemnitee of the indemnitee's good faith belief that the standards of conduct necessary for indemnification have been met and a written undertaking to reimburse the Trust unless it is subsequently determined that he is entitled to such indemnification and if a majority of the Trustees determine that the applicable standards of conduct necessary for indemnification appear to have been met. In addition, at least one of the following conditions must be met: (1) the indemnitee shall provide adequate security for his undertaking, (2) the Trust shall be insured against losses arising by reason of any lawful advances, or (3) a majority of a quorum of the Disinterested Non-Party Trustees, or if a majority vote of such quorum so direct, independent
 
 
 
C-3

 

       
legal counsel in a written opinion, shall conclude, based on a review of readily available facts (as opposed to a full trial-type inquiry), that there is substantial reason to believe that the indemnitee ultimately will be found entitled to indemnification.
         
   
(d)
 
The rights accruing to any indemnitee under these provisions shall not exclude any other right to which he may be lawfully entitled.
         
   
(e)
 
Notwithstanding the foregoing, subject to any limitations provided by the 1940 Act and this Declaration, the Trust shall have the power and authority to indemnify Persons providing services to the Trust to the full extent provided by law as if the Trust were a corporation organized under the Delaware General Corporation Law provided that such indemnification (or contractual provision therefor) has been approved by a majority of the Trustees.
 
4.3           No Duty of Investigation; Notice in Trust Instruments, etc.  No purchaser, lender, transfer agent or other person dealing with the Trustees or with any officer, employee or agent of the Trust shall be bound to make any inquiry concerning the validity of any transaction purporting to be made by the Trustees or by said officer, employee or agent or be liable for the application of money or property paid, loaned, or delivered to or on the order of the Trustees or of said officer, employee or agent. Every obligation, contract, undertaking, instrument, certificate, Share, other security of the Trust, and every other act or thing whatsoever executed in connection with the Trust shall be conclusively taken to have been executed or done by the executors thereof only in their capacity as Trustees under this Declaration or in their capacity as officers, employees or agents of the Trust. The Trustees may maintain insurance for the protection of the Trust Property, its Shareholders, Trustees, officers, employees and agents in such amount as the Trustees shall deem adequate to cover possible liability, and such other insurance as the Trustees in their sole judgment shall deem advisable or is required by the 1940 Act.
 
4.4           Reliance on Experts, etc.  Each Trustee and officer or employee of the Trust shall, in the performance of its duties, be fully and completely justified and protected with regard to any act or any failure to act resulting from reliance in good faith upon the books of account or other records of the Trust, upon an opinion of counsel, or upon reports made to the Trust by any of the Trust's officers or employees or by any advisor, administrator, manager, distributor, selected dealer, accountant, appraiser or other expert or consultant selected with reasonable care by the Trustees, officers or employees of the Trust, regardless of whether such counsel or other person may also be a Trustee.
 
Section 9 of the Registrant’s Investment Advisory Agreement provides as follows:

9.  Indemnity

(a)           The Fund hereby agrees to indemnify the Adviser and each of the Adviser’s Trustees, officers, employees, and agents (including any individual who serves at the Adviser’s request as director, officer, partner, trustee or the like of another corporation) and controlling persons (each such person being an “indemnitee”) against any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise or as fines and penalties, and counsel fees (all as provided in accordance with applicable corporate law) reasonably incurred by such indemnitee in connection with the defense or disposition of any action, suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body in which he may be or may have been involved as a party or otherwise or with which he may be or may have been threatened, while acting in any capacity set forth above in this paragraph or thereafter by reason of his having acted in any such capacity, except with respect to any matter as to which he shall have been adjudicated not to have acted in good faith in the reasonable belief that his action was in the best interest of the Fund and furthermore, in the case of any criminal proceeding, so long as he had no reasonable cause to believe that the conduct was unlawful, provided, however, that (1) no indemnitee shall be indemnified hereunder against any liability to the Fund or its shareholders or any expense of such indemnitee arising by reason of (i) willful misfeasance, (ii) bad faith, (iii) gross negligence, (iv) reckless disregard of the duties involved in the conduct of his position (the conduct referred to in such clauses (i) through (v) being sometimes referred to herein as “disabling conduct”), (2) as to any matter disposed of by settlement or a compromise payment by such indemnitee, pursuant to a consent decree or otherwise, no indemnification either for said payment or for any other expenses shall be provided unless there has been a determination that such settlement or compromise is in the best interests of the Fund and that such indemnitee appears to have acted in good faith in the reasonable belief that
 
 
 
C-4

 

his action was in the best interest of the Fund and did not involve disabling conduct by such indemnitee and (3) with respect to any action, suit or other proceeding voluntarily prosecuted by any indemnitee as plaintiff, indemnification shall be mandatory only if the prosecution of such action, suit or other proceeding by such indemnitee was authorized by a majority of the full Board of the Fund. Notwithstanding the foregoing the Fund shall not be obligated to provide any such indemnification to the extent such provision would waive any right which the Fund cannot lawfully waive.

(b)           The Fund shall make advance payments in connection with the expenses of defending any action with respect to which indemnification might be sought hereunder if the Fund receives a written affirmation of the indemnitee’s good faith belief that the standard of conduct necessary for indemnification has been met and a written undertaking to reimburse the Fund unless it is subsequently determined that he is entitled to such indemnification and if the Trustees of the Fund determine that the facts then known to them would not preclude indemnification. In addition, at least one of the following conditions must be met: (A) the indemnitee shall provide a security for his undertaking, (B) the Fund shall be insured against losses arising by reason of any lawful advances, or (C) a majority of a quorum of Trustees of the Fund who are neither “interested persons” of the Fund (as defined in Section 2(a)(19) of the Act) nor parties to the proceeding (“Disinterested Non-Party Trustees”) or an independent legal counsel in a written opinion, shall determine, based on a review of readily available facts (as opposed to a full trial-type inquiry), that there is reason to believe that the indemnitee ultimately will be found entitled to indemnification.

(c)           All determinations with respect to indemnification hereunder shall be made (1) by a final decision on the merits by a court or other body before whom the proceeding was brought that such indemnitee is not liable by reason of disabling conduct or, (2) in the absence of such a decision, by (i) a majority vote of a quorum of the Disinterested Non-party Trustees of the Fund, or (ii) if such a quorum is not obtainable or even, if obtainable, if a majority vote of such quorum so directs, independent legal counsel in a written opinion.
 
The rights accruing to any indemnitee under these provisions shall not exclude any other right to which he may be lawfully entitled.
 
Section 10 of the Registrant’s Distribution Agreement provides as follows:

10.
Indemnity and Contribution .

 
(a)
Each of the Fund and the Investment Adviser agrees to indemnify, defend and hold harmless the Distributor, its partners, directors and officers, and any person who controls the Distributor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, and the successors and assigns of all of the foregoing persons from and against any loss, damage, expense, liability or claim (including the reasonable cost of investigation) which the Distributor or any such person may incur under the Securities Act, the Exchange Act, the Investment Company Act, the Advisers Act, the common law or otherwise, insofar as such loss, damage, expense, liability or claim arises out of or is based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or in the Registration Statement as amended by any post-effective amendment thereof by the Fund) in a Prospectus (the term Prospectus for the purpose of this Section 10 being deemed to include any preliminary prospectus, any Sales Material, the Prospectus and the Prospectus as amended or supplemented by the Fund), or arises out of or is based upon any omission or alleged omission to state a material fact required to be stated in either such Registration Statement or Prospectus or necessary to make the statements made therein not misleading (with respect to the Prospectus, in light of the circumstances under which they are made), except insofar as any such loss, damage, expense, liability or claim arises out of or is based upon any untrue statement or alleged untrue statement of a material fact contained in and in conformity with information furnished in writing by or on behalf of the Distributor to the Fund or the Investment Advisor expressly for use with reference to the Distributor in such Registration Statement or such Prospectus or arises out of or is based upon any omission or alleged omission to state a material fact in connection with such information required to be stated in such Registration Statement or such Prospectus or necessary to make such information not misleading (with respect to the Prospectus, in light of the circumstances under which they were made).

 
If any action, suit or proceeding (together, a “ Proceeding ”) is brought against the Distributor or any such person in respect of which indemnity may be sought against the Fund or the Investment Adviser pursuant to the foregoing paragraph, the Distributor or such person shall promptly notify the Fund or the Investment Adviser, as the case may be, in writing of the institution of such Proceeding and the Fund or the Investment Adviser shall assume the defense of such Proceeding, including the employment of counsel reasonably satisfactory to such indemnified party and payment of all fees and expenses; provided, however, that the omission to so notify the Fund or the Investment Adviser shall not relieve the Fund or the Investment Adviser from any liability which the Fund or the Investment Adviser may have to the Distributor   or any such person or otherwise.  The Distributor or such person shall have the right to employ its or their own counsel in any such case, but the reasonable fees and expenses of such counsel shall be at the expense of the Distributor or of such person unless the employment of such counsel shall have been authorized in writing by the Fund or the Investment Adviser, as the case may be, in connection with the defense of such Proceeding or the Fund or the Investment Adviser shall not have, within a reasonable period of time in light of the circumstances, employed counsel to have charge of the defense of such Proceeding or such indemnified party or parties shall have reasonably concluded that there may be defenses available to it or them which are different from, additional to or in conflict with those available to the Fund or the Investment Adviser (in which case the Fund or the Investment Adviser shall not have the right to direct the defense of such Proceeding on behalf of the indemnified party or parties), in any of which events such fees and expenses shall be borne by the Fund or the Investment Adviser and paid as incurred (it being understood, however, that the Fund or the Investment Adviser shall not be liable for the expenses of more than one separate counsel (in addition to any local counsel) in any one Proceeding or series of related Proceedings in


 
 
C-5

 

 
 
the same jurisdiction representing the indemnified parties who are parties to such Proceeding).  Neither the Fund nor the Investment Adviser shall be liable for any settlement of any Proceeding effected without its written consent but if settled with the written consent of the Fund or the Investment Adviser, the Fund or the Investment Adviser, as the case may be, agrees to indemnify and hold harmless the Distributor and any such person from and against any loss or liability by reason of such settlement.  Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by the second sentence of this paragraph, then the indemnifying party agrees that it shall be liable for any settlement of any Proceeding effected without its written consent if (i) such settlement is entered into more than 60 business days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement and (iii) such indemnified party shall have given the indemnifying party at least 30 days’ prior notice of its intention to settle.  No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened Proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless such settlement includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such Proceeding and does not include an admission of fault, culpability or a failure to act, by or on behalf of such indemnified party.

 
(b)
The Distributor agrees to indemnify, defend and hold harmless the Fund and the Investment Adviser, their directors or trustees, as applicable, and officers, and any person who controls the Fund or the Investment Adviser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, and the successors and assigns of all of the foregoing persons from and against any loss, damage, expense, liability or claim (including the reasonable cost of investigation) which, jointly or severally, the Fund or the Investment Adviser or any such person may incur under the Securities Act, the Exchange Act, the Investment Company Act, the Advisers Act, the common law or otherwise, insofar as such loss, damage, expense, liability or claim arises out of or is based upon any untrue statement or alleged untrue statement of a material fact contained in and in conformity with information concerning the Distributor furnished in writing by or on behalf of the Distributor to the Fund or the Investment Adviser expressly for use with reference to the Distributor in the Registration Statement (or in the Registration Statement as amended by any post-effective amendment thereof by the Fund) or in a Prospectus, or arises out of or is based upon any omission or alleged omission to state a material fact in connection with such information required to be stated in such Registration Statement or such Prospectus or necessary to make such information not misleading (with respect to the Prospectus, in light of the circumstances under which they were made).

 
If any Proceeding is brought against the Fund, the Investment Adviser or any such person in respect of which indemnity may be sought against the Distributor pursuant to the foregoing paragraph, the Fund, the Investment Adviser or such person shall promptly notify the Distributor in writing of the institution of such Proceeding and the Distributor shall assume the defense of such Proceeding, including the employment of counsel reasonably satisfactory to such indemnified party and payment of all fees and expenses; provided, however, that the omission to so notify the Distributor shall not relieve the Distributor from any liability which the Distributor may have to the Fund, the Investment Adviser or any such person or otherwise.  The Fund, the Investment Adviser or such person shall have the right to employ its own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of the Fund, the Investment Adviser or such person, as the case may be, unless the employment of such counsel shall have been authorized in writing by the Distributor in connection with the defense of such Proceeding or the Distributor shall not have, within a reasonable period of time in light of the circumstances, employed counsel to have charge of the defense of such Proceeding or such indemnified party or parties shall have reasonably concluded that there may be defenses available to it or them, which are different from or additional to or in conflict with those available to the Distributor (in which case the Distributor shall not have the right to direct the defense of such Proceeding on behalf of

 
 
C-6

 

 
the indemnified party or parties, but the Distributor may employ counsel and participate in the defense thereof but the fees and expenses of such counsel shall be at the expense of the Distributor), in any of which events such fees and expenses shall be borne by the Distributor and paid as incurred (it being understood, however, that the Distributor shall not be liable for the expenses of more than one separate counsel (in addition to any local counsel) in any one Proceeding or series of related Proceedings in the same jurisdiction representing the indemnified parties who are parties to such Proceeding).  The Distributor shall not be liable for any settlement of any such Proceeding effected without the written consent of the Distributor but if settled with the written consent of the Distributor agrees to indemnify and hold harmless the Fund, the Investment Adviser and any such person from and against any loss or liability by reason of such settlement.  Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by the second sentence of this paragraph, then the indemnifying party agrees that it shall be liable for any settlement of any Proceeding effected without its written consent if (i) such settlement is entered into more than 60 business days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement and (iii) such indemnified party shall have given the indemnifying party at least 30 days’ prior notice of its intention to settle.  No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened Proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless such settlement includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such Proceeding.

 
(c)
If the indemnification provided for in this Section 10 is unavailable to an indemnified party under subsections (a) and (b) of this Section 10 in respect of any losses, damages, expenses, liabilities or claims referred to therein, then each applicable indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a result of such losses, damages, expenses, liabilities or claims (i) in such proportion as is appropriate to reflect the relative benefits received by the Fund and the Investment Adviser on the one hand and the Distributor on the other hand from the Offering of the Shares or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Fund and the Investment Adviser on the one hand and of the Distributor on the other in connection with the statements or omissions, which resulted in such losses, damages, expenses, liabilities or claims, as well as any other relevant equitable considerations.  The relative benefits received by the Fund or the Investment Adviser on the one hand and the Distributor on the other shall be deemed to be in the same respective proportions as the total proceeds from the Offering (net of Solicitation Fee but before deducting expenses) received by the Fund and the total Solicitation Fee received by the Distributor, bear to the aggregate public offering price of the Shares.  The relative fault of the Fund and the Investment Adviser on the hand and of the Distributor on the other shall be determined by reference to, among other things, whether the untrue statement or alleged untrue statement of a material fact or omission or alleged omission relates to information supplied by the Fund or the Investment Adviser or by the Distributor and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.  The amount paid or payable by a party as a result of the losses, damages, expenses, liabilities and claims referred to in this subsection shall be deemed to include any legal or other fees or expenses reasonably incurred by such party in connection with investigating, preparing to defend or defending any Proceeding.
 
 
(d)
The Fund and the Investment Adviser and the Distributor agree that it would not be just and equitable if contribution pursuant to this Section 10 were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in subsection (c) above.  Notwithstanding the provisions of this Section 10, the Distributor shall not be required to contribute any amount in excess of the fees received by the Distributor.  No
 
 
 
 
C-7

 

 
person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.

 
(e)
Notwithstanding any other provisions in this Section 10, no party shall be entitled to indemnification or contribution under this Distribution Agreement against any loss, claim, liability, expense or damage arising by reason of such person’s willful misfeasance, bad faith, or gross negligence in the performance of its duties hereunder or reckless disregard of such duties and obligations hereunder.  The parties hereto acknowledge that the foregoing provision shall not be construed to impose upon any such parties any duties under this Distribution Agreement other than specifically set forth herein (it being understood that the Distributor has no duty hereunder to the Fund or the Investment Adviser to perform any due diligence investigation).

 
(f)
The indemnity and contribution agreements contained in this Section 10 and the covenants, warranties and representations of the Fund contained in this Distribution Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the Distributor, its partners, directors or officers or any person (including each partner, officer or director of such person) who controls the Distributor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, or by or on behalf of the Fund or the Investment Adviser, its directors or officers or any person who controls the Fund or the Investment Adviser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, and shall survive any termination of this Distribution Agreement or the issuance and delivery of the Shares.  The Fund or the Investment Adviser and the Distributor agree promptly to notify each other of the commencement of any Proceeding against it and, in the case of the Fund or the Investment Adviser, against any of the Fund’s or the Investment Adviser’s directors or officers in connection with the issuance and sale of the Shares, or in connection with the Registration Statement or Prospectus.

 
(g)
The Fund and the Investment Adviser acknowledge that the statements in the Prospectus with respect to solicitation fees and reallowances of solicitation fees under the caption “Plan of Distribution” in the Prospectus, and the statement of the name and principal business address of the Distributor under the caption “Plan of Distribution” in the Prospectus, constitute the only information furnished in writing by or on behalf of the Distributor to the Fund expressly for use with reference to the Distributor in the Registration Statement or in the Prospectus (as amended or supplemented).  The Distributor confirms that these statements are correct in all material respects and were so furnished by or on behalf of the Distributor for use in the Prospectus.

 
 
 
C-8

 

 
Item 31.  Business And Other Connections Of Investment Adviser
 
The Adviser, a limited liability company organized under the laws of the State of New York, acts as investment adviser to the Registrant. The Registrant is fulfilling the requirement of this Item 31 to provide a list of the officers of the Adviser, together with information as to any other business, profession, vocation or employment of a substantial nature engaged in by the Adviser or those officers during the past two years, by incorporating by reference the information contained in the Form ADV of the Adviser filed with the SEC pursuant to the Advisers Act of 1940 (SEC File No. 801-26202).
 
Item 32.  Location Of Accounts And Records
 
The accounts and records of the Registrant are maintained in part at the office of the Adviser at One Corporate Center, Rye, New York 10580-1422, in part at the offices of the Registrant’s custodian,                                                     , at                                 in part at the offices of the Registrant’s sub-administrator,                             , at                                        and in part at the offices of the Registrant’s transfer agent,                                               , at                                       .
 
Item 33.  Management Services
Not Applicable
 
Item 34.  Undertakings
 
1.  Registrant undertakes to suspend the offering of shares until it amends its prospectus if (a) subsequent to the effective date of its Registration Statement, the net asset value declines more than ten percent from the later of its net asset value as of the effective date of the Registration Statement or the filing of a prospectus supplement pursuant to Rule 497, under the Securities Act of 1933, setting forth the terms of the offering or (b) the net asset value increases to an amount greater than its net proceeds as stated in the prospectus.
 

 
C-9

 


2.  Not applicable.

3.  Not applicable.
 
4.  Not applicable.
 
5.  Registrant undertakes that, for the purpose of determining any liability under the 1933 Act, the information omitted from the form of prospectus filed as part of the Registration Statement in reliance upon Rule 430A and contained in the form of prospectus filed by the Registrant pursuant to Rule 497(h) will be deemed to be a part of the Registration Statement as of the time it was declared effective.
 
Registrant undertakes that, for the purpose of determining any liability under the 1933 Act, each post-effective amendment that contains a form of prospectus will be deemed to be a new Registration Statement relating to the securities offered therein, and the offering of such securities at that time will be deemed to be the initial bona fide offering thereof.
 
6.  Registrant undertakes to send by first class mail or other means designed to ensure equally prompt delivery, within two business days of receipt of a written or oral request, any Statement of Additional Information constituting Part B of this Registration Statement.
 

 
C-10

 

SIGNATURES
 
Pursuant to the requirements of the Securities Act of 1933 and the Investment Company Act of 1940, the Registrant has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Rye, and State of New York, on the 12 th day of May, 2015.


 
THE GABELLI GO ANYWHERE TRUST
   
   
 
By:
 
/s/ Agnes Mullady
     
Name: 
Agnes Mullady
     
Title:
President

 
As required by the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities indicated and on the 12 th day of May, 2015.
 
     
NAME
 
TITLE
     
/s/ Agnes Mullady
 
President
Agnes Mullady
   
     
/s/ Joseph H. Egan
 
Treasurer
Joseph H. Egan
   
     
*
 
Trustee
Mario J. Gabelli
   
     
*
 
Trustee
Anthony S. Colavita
   
     
*
 
Trustee
Michael J. Cosgrove
   
     
*
 
Trustee
Frank J. Fahrenkopf, Jr.
   
     
*
 
Trustee
Michael J. Melarkey
   
     
*
 
Trustee
Kuni Nakamura
   
     


 
*By:
  /s/ Agnes Mullady
       
     
as Attorney-in-Fact


 
 
Signature Page – GGO N-2 (Pre-Eff #2)

 
 

 

 
EXHIBIT INDEX

    Exhibit No.
 
Description
     
     (a)(ii)
 
Form of Statement of Preferences for Series A Preferred Shares
     
     (e)
 
Form of Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan of Registrant
     
     (g)
 
Form of Investment Advisory Agreement between Registrant and Gabelli Funds, LLC
     
     (h)(i)   Form of Distribution Agreement
     
     (l)
 
Opinion and Consent of Skadden, Arps, Slate, Meagher & Flom LLP
     
     (p)
 
Initial Subscription Agreement
     
     (r)(i)
 
Code of Ethics of the Fund and the Adviser
     
     (r)(ii)
 
Joint Code of Ethics for Chief Executive and Senior Financial Officers of the Fund
     
     (s)
 
Power of Attorney



C-1


Exhibit (a)(ii)



 
THE GABELLI GO ANYWHERE TRUST
 
STATEMENT OF PREFERENCES
 
OF
 
SERIES A CUMULATIVE PUTTABLE AND CALLABLE PREFERRED SHARES
 
 
The Gabelli Go Anywhere Trust, a Delaware statutory trust (the “ Fund ”), hereby certifies that:
 
FIRST: The Board of Trustees of the Fund (the “ Board of Trustees ”), at a meeting duly convened and held on April 23, 2015, pursuant to authority expressly vested in it by Article V of the Agreement and Declaration of Trust, adopted resolutions classifying an unlimited amount of shares as authorized but unissued preferred shares of the Fund,  par value $0.001 per share, and delegated determination of certain terms of such preferred shares to a pricing committee of the Board of Trustees consisting of Michael J. Melarkey (Chair), Michael J. Cosgrove, and Kuni Nakamura (the “ Pricing Committee ”) at such times and in such amounts and on such terms and conditions as the Pricing Committee should determine.
 
SECOND: The Pricing Committee, at a meeting duly convened and held on [•], 2015, pursuant to the authority granted it by the Board of Trustees, approved the designation and issuance by the Fund of up to [•] shares of Series A Cumulative Puttable and Callable Preferred Shares, par value $0.001 per share (the “ Series A Preferred Shares ”).
 
THIRD: The preferences, rights, voting powers, restrictions, limitations as to dividends and distributions, qualifications, and terms and conditions of redemption of the Series A Preferred Shares, par value $0.001 per share, as set by the Pricing Committee, are as follows:
 

 
 

 
 
PART I:
 
DESIGNATION
 
Series A Preferred Shares: A series of [•] preferred shares, par value $0.001 per share, liquidation preference $40.00 per share, is hereby designated “Series A Cumulative Puttable and Callable Preferred Shares.” Each share of Series A Preferred Shares may be issued on a date to be determined by the Board of Trustees; and have such other preferences, rights, voting powers, restrictions, limitations as to dividends and distributions, qualifications and terms and conditions of redemption, in addition to those required by applicable law or set forth in the Governing Documents applicable to Preferred Shares of the Fund, as are set forth in this Statement of Preferences. The Series A Preferred Shares shall constitute a separate series of Preferred Shares.
 
DEFINITIONS
 
Unless the context or use indicates another or different meaning or intent, each of the following terms when used in this Statement of Preferences shall have the meaning ascribed to it below, whether such term is used in the singular or plural and regardless of tense:
 
1940 Act ” means the Investment Company Act of 1940, as amended, or any successor statute.
 
Administrator ” means Gabelli Funds, LLC, a New York limited liability company, or such other entity as shall be providing administrative services to the Fund and will include, as appropriate, any sub-administrator appointed by the Administrator.
 
Adviser ” means Gabelli Funds, LLC, a New York limited liability company, or such other entity as shall be serving as the investment adviser of the Fund.
 
Asset Coverage ” means asset coverage, as determined in accordance with Section 18(h) of the 1940 Act, of at least 200% with respect to all outstanding senior securities of the Fund which are stock, including all Outstanding Series A Preferred Shares (or such other asset coverage as may in the future be specified in or under the 1940 Act as the minimum asset coverage for senior securities which are stock of a closed-end investment company as a condition of declaring dividends on its common stock), determined on the basis of values calculated as of a time within 48 hours (not including Sundays or holidays) next preceding the time of such determination.
 
Board of Trustees ” means the Board of Trustees of the Fund or any duly authorized committee thereof as permitted by applicable law.
 
Business Day ” means a day on which the New York Stock Exchange is open for trading.
 
By-Laws ” means the By-Laws of the Fund as amended from time to time by the Trustees.
 
Common Shares ” means the common shares of beneficial interest, par value $0.001 per share, of the Fund.
 

 
2

 
 
Commission ” means the Securities and Exchange Commission.
 
Cure Date ” shall have the meaning set forth in paragraph 4(a) of Part II hereof.
 
Date of Original Issue ” means [•], 2015, and for the purposes of this Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares.
 
Declaration of Trust ” means the Agreement and Declaration of Trust of the Fund, dated as of February 26, 2015, as amended, supplemented or restated from time to time (including by this Statement of Preferences or by way of any other supplement or Statement of Preferences authorizing or creating a class or series of a class of shares of beneficial interest in the Fund).
 
Deposit Assets ” means cash, Short-Term Money Market Instruments and U.S. Government Obligations. Each Deposit Asset shall be deemed to have a value equal to its principal or face amount payable at maturity plus any interest payable thereon after delivery of such Deposit Asset but only if payable on or prior to the applicable payment date in advance of which the relevant deposit is made.
 
Dividend Disbursing Agent ” means, with respect to the Series A Preferred Shares, Computershare Trust Company, N.A. and its successors or any other dividend disbursing agent appointed by the Fund with respect to the Series A Preferred Shares and, with respect to any other class or series of Preferred Shares, the entity appointed by the Fund as dividend disbursing or paying agent with respect to such class or series.
 
Dividend Payment Date ” means with respect to the Series A Preferred Shares, any date on which dividends and distributions declared by the Board of Trustees thereon are payable pursuant to the provisions of paragraph 2(a) of Part II of this Statement of Preferences and shall for the purposes of this Statement of Preferences have a correlative meaning with respect to any other class or series of Preferred Shares.
 
Dividend Period ” shall have the meaning set forth in paragraph 2(a) of Part II hereof.
 
Fund ” means The Gabelli Go Anywhere Trust.
 
Governing Documents ” means the Declaration of Trust and the By-Laws.
 
Liquidation Preference ” shall, with respect to the Series A Preferred Shares, have the meaning set forth in paragraph 3(a) of Part II hereof, and for the purposes of this Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares.
 
Outstanding ” means, as of any date, Preferred Shares theretofore issued by the Fund except:
 
(a)           such Preferred Share theretofore cancelled by the Fund or delivered to the Fund for cancellation;
 

 
3

 
 
(b)           any such Preferred Share as to which a notice of redemption shall have been given and for whose payment at the redemption thereof Deposit Assets in the necessary amount are held by the Fund in trust for, or have been irrevocably deposited with the relevant disbursing agent for payment to, the holder of such share pursuant to the Statement of Preferences with respect thereto; and
 
(c)           such Preferred Share in exchange for or in lieu of which other shares have been issued and delivered.
 
Notwithstanding the foregoing, for purposes of voting rights (including the determination of the number of shares required to constitute a quorum), any Preferred Shares as to which the Fund or any subsidiary of the Fund is the holder will be disregarded and deemed not Outstanding.
 
Person ” means and includes an individual, a partnership, the Fund, a trust, a corporation, a limited liability company, an unincorporated association, a joint venture or other entity or a government or any agency or political subdivision thereof.
 
Preferred Shares ” means the preferred shares, par value $0.001 per share, of the Fund, and includes the Series A Preferred Shares.
 
Preferred Share Asset Coverage Cure Date ” means, with respect to the failure by the Fund to maintain Asset Coverage (as required by paragraph 6(a)(i) of Part II hereof) as of the last Business Day of each March, June, September and December of each year, 60 calendar days following such Business Day.
 
Redemption Price ” has the meaning set forth in paragraph 4(a) of Part II hereof, and for the purposes of this Statement of Preferences shall have a correlative meaning with respect to any other class or series of Preferred Shares.
 
Series A Preferred Shares ” means the Series A Preferred Shares of the Fund.
 
Short-Term Money Market Instruments ” means shares of investment funds qualifying as “ money market funds ” under Rule 2a-7 or any successor rule of the 1940 Act and the following types of instruments if, on the date of purchase or other acquisition thereof by the Fund, the remaining term to maturity thereof is not in excess of 180 days:
 
(a)           commercial paper rated A-1 if such commercial paper matures within 30 days or A-1+ if such commercial paper matures in over 30 days;
 
(b)           demand or time deposits in, and banker’s acceptances and certificates of deposit of (A) a depository institution or trust company incorporated under the laws of the United States of America or any state thereof or the District of Columbia or (B) a United States branch office or agency of a foreign depository institution ( provided that such branch office or agency is subject to banking regulation under the laws of the United States, any state thereof or the District of Columbia);
 
(c)           overnight funds; and
 

 
4

 
 
(d)           U.S. Government Obligations.
 
U.S. Government Obligations ” means direct obligations of the United States or obligations issued by its agencies or instrumentalities that are entitled to the full faith and credit of the United States and that, other than United States Treasury Bills, provide for the periodic payment of interest and the full payment of principal at maturity or call for redemption.
 
Voting Period ” shall have the meaning set forth in paragraph 5(b) of Part II hereof.
 
PART II:
 
SERIES A CUMULATIVE PUTTABLE AND CALLABLE PREFERRED SHARES
 
1.             Number of Shares; Ranking .
 
(a)           The initial number of authorized shares constituting the Series A Preferred Shares to be issued is [•]. No fractional Series A Preferred Shares shall be issued.
 
(b)           Series A Preferred Shares which at any time have been redeemed or purchased by the Fund shall, after such redemption or purchase, have the status of authorized but unissued Preferred Shares.
 
(c)           The Series A Preferred Shares shall rank on a parity with any other series of Preferred Shares as to the payment of dividends and liquidation preference to which such Shares are entitled.
 
(d)           No Holder of Series A Preferred Shares shall have, solely by reason of being such a holder, any preemptive or other right to acquire, purchase or subscribe for any Preferred Shares or Common Shares or other securities of the Fund which it may hereafter issue or sell.
 
2.             Dividends and Distributions .
 
(a)           The holders of Series A Preferred Shares shall be entitled to receive, when, as and if declared by, or under authority granted by, the Board of Trustees, out of funds legally available therefor, cumulative cash dividends and distributions, calculated separately for each dividend period and payable quarterly on March 26, June 26, September 26, and December 26 in each year (each, a “ Dividend Payment Date ”) and commencing on [•], 2015 (or if any such day is not a Business Day, then on the next succeeding Business Day), and computed on the basis of a 360-day year consisting of twelve 30-day months, on the liquidation preference of $40.00 per Series A Preferred Share. For the dividend periods ending on or prior to [•], 2016, such dividends will be paid at the annualized rate of 8.00% based on the liquidation preference of the Series A Preferred Shares. Thereafter, for the eight dividend periods occurring after [•], 2016, but ending on or prior to [•], 2018, such dividends will be paid at an annualized rate of 5.00% based on the liquidation preference of the Series A Preferred Shares.  During the dividend period ending [•], 2018, and during each dividend period ending [•] in each subsequent year, the Fund’s Board of Trustees will determine and publicly announce at least 60 days prior to the end of such period a fixed annual dividend rate that will apply for the subsequent four dividend
 

 
5

 
 
periods. Such rate will be 200 basis points over the yield of the ten year U.S. Treasury Note at the date such rate is fixed by the Board of Trustees; provided that, in no case will the annual dividend rate for dividend periods commencing after [•], 2018 be less than 5.00% or greater than 7.00% based on the liquidation preference of the Series A Preferred Shares. Dividends will be paid to holders of record of Series A Preferred Shares as they appear on the stock register of the Fund at the close of business on the fifth preceding Business Day of a Dividend Payment Date in preference to dividends and distributions on Common Shares and any other capital shares of the Fund ranking junior to the Series A Preferred Shares in payment of dividends and distributions. Dividends and distributions on Series A Preferred Shares shall accumulate from the date on which such shares are originally issued. Each period beginning on and including a Dividend Payment Date (or the Date of Original Issue, in the case of the first dividend period after issuance of such shares) and ending on but excluding the next succeeding Dividend Payment Date is referred to herein as a “ Dividend Period .” Dividends and distributions on account of arrears for any past Dividend Period or in connection with the redemption of Series A Preferred Shares may be declared and paid at any time, without reference to any Dividend Payment Date, to holders of record on such date as shall be fixed by the Board of Trustees.
 
(b)           (i)           No full dividends and distributions shall be declared or paid on Series A Preferred Shares for any Dividend Period or part thereof unless full cumulative dividends and distributions due through the most recent Dividend Payment Dates therefor for all series of Preferred Shares of the Fund ranking on a parity with the Series A Preferred Shares as to the payment of dividends and distributions have been or contemporaneously are declared and paid through the most recent Dividend Payment Dates therefor. If full cumulative dividends and distributions due have not been paid on all such Outstanding Preferred Shares, any dividends and distributions being paid on such Preferred Shares (including the Series A Preferred Shares) will be paid as nearly pro rata as possible in proportion to the respective amounts of dividends and distributions accumulated but unpaid on each such series of Preferred Shares on the relevant Dividend Payment Date. No holders of Series A Preferred Shares shall be entitled to any dividends and distributions, whether payable in cash, property or shares, in excess of full cumulative dividends and distributions as provided in this paragraph 2(b)(i) on Series A Preferred Shares. No interest or sum of money in lieu of interest shall be payable in respect of any dividend payments on any Series A Preferred Shares that may be in arrears.
 
(ii)           For so long as Series A Preferred Shares are Outstanding, the Fund shall not declare any dividend or any other distribution (other than a dividend or distribution paid in Common Shares, or options, warrants or rights to subscribe for or purchase Common Shares or other shares, if any, ranking junior to the Series A Preferred Shares as to dividends and distributions and upon liquidation) in respect of the Common Shares or any other shares of the Fund ranking junior to the Series A Preferred Shares as to the payment of dividends and distributions and upon liquidation, or call for redemption, redeem, purchase or otherwise acquire for consideration any Common Shares or any other shares of the Fund ranking junior to the Series A Preferred Shares as to the payment of dividends and distributions and upon liquidation (except by conversion into or exchange for shares of the Fund ranking junior to the Series A Preferred Shares as to dividends and distributions and upon liquidation), unless, in each case, (A) immediately thereafter, the Fund shall have Asset Coverage, (B) all cumulative dividends and distributions on all Series A Preferred Shares due on or prior to the date of the
 

 
6

 
 
transaction have been declared and paid (or shall have been declared and sufficient funds for the payment thereof deposited with the applicable Dividend Disbursing Agent) and (C) the Fund has redeemed the full number of Series A Preferred Shares to be redeemed mandatorily pursuant to any provision contained herein for mandatory redemption.
 
(iii)           Any dividend payment made on the Series A Preferred Shares shall first be credited against the dividends and distributions accumulated with respect to the earliest Dividend Period for which dividends and distributions have not been paid.
 
(c)           Not later than the Business Day immediately preceding each Dividend Payment Date, the Fund shall deposit with the Dividend Disbursing Agent Deposit Assets having an initial combined value sufficient to pay the dividends and distributions that are payable on such Dividend Payment Date, which Deposit Assets shall mature or be redeemable on or prior to such Dividend Payment Date. The Fund may direct the Dividend Disbursing Agent with respect to the investment of any such Deposit Assets, provided that such investment consists exclusively of Deposit Assets and provided further that the proceeds of any such investment will be available at the opening of business on such Dividend Payment Date.
 
3.             Liquidation Rights .
 
(a)           In the event of any liquidation, dissolution or winding up of the affairs of the Fund, whether voluntary or involuntary, the holders of Series A Preferred Shares shall be entitled to receive out of the assets of the Fund available for distribution to shareholders, after satisfying claims of creditors but before any distribution or payment shall be made in respect of the Common Shares or any other shares of the Fund ranking junior to the Series A Preferred Shares as to liquidation payments, a liquidation distribution in the amount of $40.00 per share (the “ Liquidation Preference ”), plus an amount equal to all unpaid dividends and distributions accumulated to and including the date fixed for such distribution or payment to the holders of Series A Preferred Shares (whether or not earned or declared by the Fund, but excluding interest thereon), and such holders shall be entitled to no further participation in any distribution or payment in connection with any such liquidation, dissolution or winding up.
 
(b)           If, upon any liquidation, dissolution or winding up of the affairs of the Fund, whether voluntary or involuntary, the assets of the Fund available for distribution among the holders of all Outstanding Series A Preferred Shares, and any other Outstanding class or series of Preferred Shares of the Fund ranking on a parity with the Series A Preferred Shares as to payment upon liquidation, shall be insufficient to permit the payment in full to such holders of Series A Preferred Shares of the Liquidation Preference plus accumulated and unpaid dividends and distributions and the amounts due upon liquidation with respect to such other Preferred Shares, then such available assets shall be distributed among the holders of Series A Preferred Shares and such other Preferred Shares ratably in proportion to the respective preferential liquidation amounts to which they are entitled. Unless and until the Liquidation Preference plus accumulated and unpaid dividends and distributions has been paid in full (or set aside for such payment) to the holders of Series A Preferred Shares, no dividends or distributions will be made to holders of the Common Shares or any other shares of the Fund ranking junior to the Series A Preferred Shares as to liquidation.
 

 
7

 
 
4.             Redemptions .
 
The Series A Preferred Shares shall be redeemed by the Fund as provided below:
 
(a)           Mandatory Redemptions.
 
If the Fund is required to redeem any Preferred Shares (which may include Series A Preferred Shares) pursuant to paragraphs 6(b) or 6(c) of Part II hereof, then the Fund shall, to the extent permitted by the 1940 Act and Delaware law, by the close of business on such Preferred Share Asset Coverage Cure Date (herein referred to as a “ Cure Date ”), as the case may be, fix a redemption date and proceed to redeem shares as set forth in paragraph 4(c) hereof. On such redemption date, the Fund shall redeem, out of funds legally available therefor, the number of Preferred Shares, which, to the extent permitted by the 1940 Act and Delaware law, at the option of the Fund may include any proportion of Series A Preferred Shares or any other series of Preferred Shares, equal to the minimum number of shares the redemption of which, if such redemption had occurred immediately prior to the opening of business on such Cure Date, would have resulted in the Fund having Asset Coverage immediately prior to the opening of business on such Cure Date or, if Asset Coverage cannot be so restored, all of the Outstanding Series A Preferred Shares, at a price equal to $40.00 per share plus accumulated but unpaid dividends and distributions (whether or not earned or declared by the Fund) through the date of redemption (the “ Redemption Price ”). In the event that Preferred Shares are redeemed pursuant to paragraphs 6(b) or 6(c) of Part II hereof, the Fund may, but is not required to, redeem a sufficient number of Series A Preferred Shares pursuant to this paragraph 4(a) which, when aggregated with other Preferred Shares redeemed by the Fund, permits the Fund to have with respect to the Preferred Shares (including the Series A Preferred Shares) remaining Outstanding after such redemption, Asset Coverage of as much as 220%. In the event that all of the Series A Preferred Shares then Outstanding are required to be redeemed pursuant to paragraph 6 of Part II hereof, the Fund shall redeem such shares at the Redemption Price and proceed to do so as set forth in paragraph 4(c) hereof.
 
(b)           Optional Redemptions.
 
The Fund may redeem all or any part of the Preferred Shares, upon not less than 30 nor more than 60 days’ prior notice, at the Redemption Price, at any time on or after [•], 2020. Additionally, prior to [•], 2020, the Fund may also redeem all or any part of the Preferred Shares, upon not less than 30 nor more than 60 days’ prior notice, at the Redemption Price, at any time if such redemption is necessary, in the judgment of the Board of Trustees, to maintain the Fund’s status as a “regulated investment company” under Subchapter M of the Internal Revenue Code of 1986, as amended.
 
(c)           Procedures for Redemption.
 
(i)           If the Fund shall determine or be required to redeem Series A Preferred Shares pursuant to this paragraph 4, it shall mail a written notice of redemption (“ Notice of Redemption ”) with respect to such redemption by first class mail, to each holder of the shares to be redeemed at such holder’s address as the same appears on the stock register of the Fund on the close of business on such date as the Board of Trustees
 

 
8

 
 
or its delegatee may determine, which date shall not be earlier than the second Business Day prior to the date upon which such Notice of Redemption is mailed to the holders of Series A Preferred Shares. Each such Notice of Redemption shall state: (A) the redemption date as established by the Board of Trustees or its delegatee; (B) the number of Series A Preferred Shares to be redeemed; (C) the CUSIP number(s) of such shares; (D) the Redemption Price (specifying the amount of accumulated dividends to be included therein); (E) the place or places where the certificate(s) for such shares (properly endorsed or assigned for transfer, if the Board of Trustees or its delegatee shall so require and the Notice of Redemption shall so state) are to be surrendered for payment in respect of such redemptions; (F) that dividends and distributions on the shares to be redeemed will cease to accumulate on such redemption date; (G) the provisions of this paragraph 4 under which such redemption is made; and (H) in the case of a redemption pursuant to paragraph 4(b), any conditions precedent to such redemption. No defect in the Notice of Redemption or the mailing thereof shall affect the validity of the redemption proceedings, except as required by applicable law.
 
(ii)           If the Fund shall give a Notice of Redemption, then by the close of business on the Business Day preceding the redemption date specified in the Notice of Redemption (so long as any conditions precedent to such redemption have been met) or, if the Dividend Disbursing Agent so agrees, another date not later than the redemption date, the Fund shall (A) deposit with the Dividend Disbursing Agent Deposit Assets that shall mature on or prior to such redemption date having an initial combined value sufficient to effect the redemption of the Series A Preferred Shares to be redeemed and (B) give the Dividend Disbursing Agent irrevocable instructions and authority to pay the Redemption Price to the holders of the Series A Preferred Shares called for redemption on the redemption date. The Fund may direct the Dividend Disbursing Agent with respect to the investment of any Deposit Assets so deposited, provided that the proceeds of any such investment will be available at the opening of business on such redemption date. Upon the date of such deposit (unless the Fund shall default in making payment of the Redemption Price), all rights of the holders of the Series A Preferred Shares so called for redemption shall cease and terminate except the right of the holders thereof to receive the Redemption Price thereof and such shares shall no longer be deemed Outstanding for any purpose. The Fund shall be entitled to receive, promptly after the date fixed for redemption, any cash in excess of the aggregate Redemption Price of the Series A Preferred Shares called for redemption on such date and any remaining Deposit Assets. Any assets so deposited that are unclaimed at the end of two years from such redemption date shall, to the extent permitted by law, be repaid to the Fund, after which the holders of the Series A Preferred Shares so called for redemption shall look only to the Fund for payment of the Redemption Price thereof. The Fund shall be entitled to receive, from time to time after the date fixed for redemption, any interest on the Deposit Assets so deposited.
 
(iii)           On or after the redemption date, each holder of Series A Preferred Shares that are subject to redemption shall surrender the certificate evidencing such shares to the Fund at the place designated in the Notice of Redemption in accordance with the procedures specified by the Fund and only upon such qualifying surrender shall then be entitled to receive the cash Redemption Price, without interest.
 

 
9

 
 
(iv)           In the case of any redemption of less than all of the Series A Preferred Shares pursuant to this Statement of Preferences, such redemption shall be made (A) pro rata from each holder of Series A Preferred Shares in accordance with the respective number of shares held by each such holder on the record date for such redemption or (B) by lot or such other equitable methodology consistent with the 1940 Act as the Dividend Disbursing Agent shall determine after consultation with the Fund.
 
(v)           Notwithstanding the other provisions of this paragraph 4, the Fund shall not redeem Series A Preferred Shares unless all accumulated and unpaid dividends and distributions on all Outstanding Series A Preferred Shares and other Preferred Shares ranking on a parity with the Series A Preferred Shares with respect to dividends and distributions for all applicable past Dividend Periods (whether or not earned or declared by the Fund) shall have been or are contemporaneously paid or declared and Deposit Assets for the payment of such dividends and distributions shall have been deposited with the Dividend Disbursing Agent as set forth in paragraph 2(c) of Part II hereof; provided ,   however that the foregoing shall not prevent the purchase or acquisition of outstanding Preferred Shares pursuant to the successful completion of an otherwise lawful purchase or exchange offer made on the same terms to holders of all Outstanding Series A Preferred Shares or pursuant to any other lawful means.
 
If the Fund shall not have funds legally available for the redemption of, or is otherwise unable to redeem all the Series A Preferred Shares or other Preferred Shares designated to be redeemed on any redemption date, the Fund shall redeem on such redemption date the number of Series A Preferred Shares and other Preferred Shares so designated as it shall have legally available funds, or is otherwise able, to redeem ratably on the basis of the Redemption Price from each holder whose shares are to be redeemed, and the remainder of the Series A Preferred Shares and other Preferred Shares designated to be redeemed shall be redeemed on the earliest practicable date on which the Fund shall have funds legally available for the redemption of, or is otherwise able to redeem, such shares upon Notice of Redemption.
 
5.             Voting Rights .
 
(a)           General.
 
Except as otherwise provided in the Governing Documents or a resolution of the Board of Trustees or its delegatee, or as required by applicable law, holders of Series A Preferred Shares shall have no power to vote on any matter except matters submitted to a vote of the Common Shares. Subject to the requirements of the 1940 Act, in any matter submitted to a vote of the holders of the outstanding capital shares of the Fund, each holder of Series A Preferred Shares shall be entitled to one vote for each Series A Preferred Share held, and the holders of the Outstanding Preferred Shares, including Series A Preferred Shares, and the Common Shares shall vote together as a single class; provided , however , that at any meeting of the shareholders of the Fund held for the election of Trustees, the holders of the Outstanding Preferred Shares, including Series A Preferred Shares, shall be entitled, as a class, to the exclusion of the holders of all other securities and classes of capital shares of the Fund, to elect a number of Fund trustees, such that following the election of trustees at the meeting of the shareholders, the Fund’s Board of Trustees shall contain two trustees elected by the holders of the Outstanding
 

 
10

 
 
Preferred Shares, including the Series A Preferred Shares. Subject to paragraph 5(b) of Part II hereof, the holders of the outstanding capital shares of the Fund, including the holders of Outstanding Preferred Shares, including the Series A Preferred Shares, voting as a single class, shall elect the balance of the trustees.
 
(b)           Right to Elect Majority of Board of Trustees.
 
During any period in which any one or more of the conditions described below shall exist (such period being referred to herein as a “ Voting Period ”), the number and/or composition of trustees constituting the Board of Trustees shall be adjusted as necessary to permit the holders of Outstanding Preferred Shares, including the Series A Preferred Shares, voting separately as one class (to the exclusion of the holders of all other securities and classes of capital shares of the Fund) to elect the number of trustees that, when added to the two trustees elected exclusively by the holders of Preferred Shares pursuant to paragraph 5(a) above, would constitute a simple majority of the Board of Trustees as so adjusted. The Fund and the Board of Trustees shall take all necessary actions, including effecting the removal of trustees or amendment of the Fund Declaration of Trust, to effect an adjustment of the number and/or composition of trustees as described in the preceding sentence. A Voting Period shall commence:
 
(i)           if at any time accumulated dividends and distributions (whether or not earned or declared, and whether or not funds are then legally available in an amount sufficient therefor) on the Outstanding Series A Preferred Shares equal to at least two full years’ dividends and distributions shall be due and unpaid and sufficient cash or specified securities shall not have been deposited with the Dividend Disbursing Agent for the payment of such accumulated dividends and distributions; or
 
(ii)           if at any time holders of any other Preferred Shares are entitled to elect a majority of the Trustees of the Fund under the 1940 Act or Statement of Preferences creating such shares.
 
Upon the termination of a Voting Period, the voting rights described in this paragraph 5(b) shall cease, subject always, however, to the reverting of such voting rights in the holders of Preferred Shares upon the further occurrence of any of the events described in this paragraph 5(b).
 
(c)           Right to Vote with Respect to Certain Other Matters.
 
Subject to paragraph 1 of Part III of this Statement of Preferences, so long as any Series A Preferred Shares are Outstanding, the Fund shall not amend, alter or repeal the provisions of this Statement of Preferences so as to in the aggregate adversely affect the rights and preferences set forth in any Statement of Preferences, including the Series A Preferred Shares, without the affirmative vote of the holders of a majority (as defined in the 1940 Act) of the Preferred Shares Outstanding at the time and present and voting on such matter, voting separately as one class. To the extent permitted under the 1940 Act, in the event that more than one series of Preferred Shares are Outstanding, the Fund shall not effect any of the actions set forth in the preceding sentence which in the aggregate adversely affects the rights and preferences set forth in the Statement of Preferences for a series of Preferred Shares differently
 

 
11

 
 
than such rights and preferences for any other series of Preferred Shares without the affirmative vote of the holders of at least a majority of the Preferred Shares Outstanding and present and voting on such matter of each series adversely affected (each such adversely affected series voting separately as a class to the extent its rights are affected differently). The holders of the Series A Preferred Shares shall not be entitled to vote on any matter that affects the rights or interests of only one or more other series of Preferred Shares. Unless a higher percentage is required under the Governing Documents or applicable provisions of the Delaware Statutory Trust Act or the 1940 Act, the affirmative vote of the holders of a majority of the Outstanding Preferred Shares, including Series A Preferred Shares, voting together as a single class, will be required to approve any plan of reorganization adversely affecting the Preferred Shares or any action requiring a vote of security holders under Section 13(a) of the 1940 Act. For purposes of this paragraph 5(c), the phrase “vote of the holders of a majority of the Outstanding Preferred Shares” or series or series thereof (or any like phrase) shall mean, in accordance with Section 2(a)(42) of the 1940 Act, the vote, at the annual or a special meeting of the shareholders of the Fund duly called (i) of 67 percent or more of the Preferred Shares or series or series thereof present at such meeting, if the holders of more than 50 percent of the Outstanding Preferred Shares or series or series thereof are present or represented by proxy; or (ii) of more than 50 percent of the Outstanding Preferred Shares or series or series thereof, whichever is less. The class vote of holders of Preferred Shares described above will in each case be in addition to a separate vote of the requisite percentage of Common Shares and Preferred Shares, including Series A Preferred Shares, voting together as a single class, necessary to authorize the action in question. An increase in the number of authorized Preferred Shares pursuant to the Governing Documents or the issuance of additional shares of any series of Preferred Shares (including Series A Preferred Shares) pursuant to the Governing Documents shall not be considered to adversely affect the rights and preferences of the Preferred Shares.
 
(d)           Voting Procedures.
 
(i)           As soon as practicable after the accrual of any right of the holders of Preferred Shares to elect additional trustees as described in paragraph 5(b) above, the Fund shall call a special meeting of such holders and instruct the Dividend Disbursing Agent to mail a notice of such special meeting to such holders, such meeting to be held not less than 10 nor more than 30 days after the date of mailing of such notice. If the Fund fails to send such notice to the Dividend Disbursing Agent or if the Fund does not call such a special meeting, it may be called by any such holder on like notice. The record date for determining the holders entitled to notice of and to vote at such special meeting shall be the close of business on the day on which such notice is mailed or such other date as the Board of Trustees shall determine. At any such special meeting and at each meeting held during a Voting Period, such holders of Preferred Shares, voting together as a class (to the exclusion of the holders of all other securities and classes of capital shares of the Fund), shall be entitled to elect the number of trustees prescribed in paragraph 5(b) above on a one-vote-per-share basis. At any such meeting, or adjournment thereof in the absence of a quorum, a majority of such holders present in person or by proxy shall have the power to adjourn the meeting without notice, other than by an announcement at the meeting, to a date not more than 120 days after the original record date.
 

 
12

 
 
 
(ii)           For purposes of determining any rights of the holders of Series A Preferred Shares to vote on any matter or the number of shares required to constitute a quorum, whether such right is created by this Statement of Preferences, by the other provisions of the Governing Documents, by statute or otherwise, any Series A Preferred Share which is not Outstanding shall not be counted.
 
(iii)           The terms of office of all persons who are trustees of the Fund at the time of a special meeting of holders of Preferred Shares to elect trustees and who remain trustees following such meeting shall continue, notwithstanding the election at such meeting by such holders of the number of trustees that they are entitled to elect, and the persons so elected by such holders, together with the two incumbent trustees elected by the holders of Preferred Shares, and the remaining incumbent trustees elected by the holders of the Common Shares and Preferred Shares, shall constitute the duly elected trustees of the Fund.
 
(iv)           Upon the expiration of a Voting Period, the terms of office of the additional trustees elected by the holders of Preferred Shares pursuant to paragraph 5(b) above shall expire at the earliest time permitted by law, and the remaining trustees shall constitute the trustees of the Fund and the voting rights of such holders of Preferred Shares, including Series A Preferred Shares, to elect additional trustees pursuant to paragraph 5(b) above shall cease, subject to the provisions of the last sentence of paragraph 5(b). Upon the expiration of the terms of the trustees elected by the holders of Preferred Shares pursuant to paragraph 5(b) above, the number of trustees shall be automatically reduced to the number of trustees on the Board immediately preceding such Voting Period.
 
(e)           Puts.
 
The Fund will repurchase all or any part of the Series A Preferred Shares that holders have properly tendered for redemption during the 30-day period prior to each of [•], 2018 and [•], 2020, at the liquidation preference, plus any accumulated and unpaid dividends.
 
(f)           Exclusive Remedy.
 
Unless otherwise required by law, the holders of Series A Preferred Shares shall not have any rights or preferences other than those specifically set forth herein. The holders of Series A Preferred Shares shall have no preemptive rights or rights to cumulative voting. In the event that the Fund fails to pay any dividends and distributions on the Series A Preferred Shares or fails to complete any voluntary or mandatory redemption, the exclusive remedy of the holders shall be the right to vote for trustees pursuant to the provisions of this paragraph 5.
 
6.             Coverage Tests .
 
(a)           Determination of Compliance.
 
For so long as any Series A Preferred Shares are Outstanding, the Fund shall make the following determinations:
 

 
13

 
 
(i)           Asset Coverage. The Fund shall have Asset Coverage as of the last Business Day of each March, June, September and December of each year in which any Series A Preferred Shares are Outstanding.
 
(b)           Failure to Meet Asset Coverage.
 
If the Fund fails to have Asset Coverage as provided in paragraph 6(a)(i) hereof and such failure is not cured as of the related Preferred Share Asset Coverage Cure Date, (i) the Fund shall give a Notice of Redemption as described in paragraph 4 of Part II hereof with respect to the redemption of a sufficient number of Preferred Shares, which at the Fund’s determination (to the extent permitted by the 1940 Act and Delaware law) may include any proportion of Series A Preferred Shares, to enable it to meet the requirements of paragraph 6(a)(i) above, and, at the Fund’s discretion, such additional number of Series A Preferred Shares or other Preferred Shares in order that the Fund have Asset Coverage with respect to the Series A Preferred Shares and any other Preferred Shares remaining Outstanding after such redemption as great as 220%, and (ii) deposit with the Dividend Disbursing Agent Deposit Assets having an initial combined value sufficient to effect the redemption of the Series A Preferred Shares or other Preferred Shares to be redeemed, as contemplated by paragraph 4 of Part II hereof.
 
(c)           Status of Shares Called for Redemption.
 
For purposes of determining whether the requirements of paragraph 6(a)(i) hereof are satisfied, (i) no Series A Preferred Share shall be deemed to be Outstanding for purposes of any computation if, prior to or concurrently with such determination, sufficient Deposit Assets to pay the full Redemption Price for such share shall have been deposited in trust with the Dividend Disbursing Agent (or applicable paying agent) and the requisite Notice of Redemption shall have been given, and (ii) such Deposit Assets deposited with the Dividend Disbursing Agent (or paying agent) shall not be included.
 
7.             Limitation on Incurrence of Additional Indebtedness and Issuance of Additional Preferred Shares .
 
(a)           So long as any Series A Preferred Shares are Outstanding the Fund may issue and sell one or more series of a class of senior securities of the Fund representing indebtedness under Section 18 of the 1940 Act and/or otherwise create or incur indebtedness, provided that immediately after giving effect to the incurrence of such indebtedness and to its receipt and application of the proceeds thereof, the Fund shall have an “asset coverage” for all senior securities representing indebtedness, as defined in Section 18(h) of the 1940 Act, of at least 300%, and no such additional indebtedness shall have any preference or priority over any other indebtedness of the Fund constituting senior securities upon the distribution of the assets of the Fund or in respect of the payment of interest. Any possible liability resulting from lending and/or borrowing portfolio securities, entering into reverse repurchase agreements, entering into futures contracts and writing options, to the extent such transactions are made in accordance with the investment restrictions of the Fund then in effect, shall not be considered to be indebtedness limited by this paragraph 7(a).
 

 
14

 
 
(b)           So long as any Series A Preferred Shares are Outstanding, the Fund may issue and sell shares of one or more other series of Preferred Shares constituting a series of a class of senior securities of the Fund representing stock under Section 18 of the 1940 Act in addition to the Series A Preferred Shares, provided that (i) the Fund shall, immediately after giving effect to the issuance of such additional Preferred Shares and to its receipt and application of the proceeds thereof, including, without limitation, to the redemption of Preferred Shares for which a Redemption Notice has been mailed prior to such issuance, have an “asset coverage” for all senior securities which are stock, as defined in Section 18(h) of the 1940 Act, of at least 200%, and (ii) no such additional Preferred Shares shall have any preference or priority over any other Preferred Shares of the Fund upon the distribution of the assets of the Fund or in respect of the payment of dividends.
 
PART III:
 
ABILITY OF THE BOARD OF TRUSTEES TO MODIFY THE STATEMENT OF PREFERENCES
 
1.             Modification .
 
To the extent permitted by law, the Board of Trustees or its delegatee, without the vote of the holders of the Series A Preferred Shares or any other capital shares of the Fund, may amend the provisions of this Statement of Preferences to resolve any inconsistency or ambiguity or to remedy any formal defect so long as the amendment does not in the aggregate adversely affect the rights and preferences of the Series A Preferred Shares.
 

 
15

 

 
IN WITNESS WHEREOF, The Gabelli Go Anywhere Trust has caused these presents to be signed in its name and on its behalf by a duly authorized officer, who acknowledges said instrument to be the corporate act of the Fund, and states that to the best of such officer’s knowledge, information and belief under penalty of perjury the matters and facts herein set forth with respect to approval are true in all material respects, all as of [•], 2015.
 
 
 
THE GABELLI GO ANYWHERE TRUST
       
       
 
By:
     
     
Name:
     
Title:



16
Exhibit (e)
 

AUTOMATIC DIVIDEND REINVESTMENT
AND VOLUNTARY CASH PURCHASE PLANS
 
Enrollment in the Plan
 
It is the policy of The Gabelli Go Anywhere Trust (the "Fund") to automatically reinvest dividends payable to common shareholders. As a "registered" shareholder you automatically become a participant in the Fund's Automatic Dividend Reinvestment Plan (the Plan"). The Plan authorizes the Fund to credit shares of common stock to participants upon an income dividend or a capital gains distribution regardless of whether the shares are trading at a discount or a premium to net asset value. All distributions to shareholders whose shares are registered in their own names will be automatically reinvested pursuant to the Plan in additional shares of the Fund. Plan participants may send their stock certificates to [ ] to be held in their dividend reinvestment account. Registered shareholders wishing to receive their distributions in cash must submit this request in writing to:
 
 
The Gabelli Go Anywhere Trust
   
 
c/o [ ]
 
Shareholders requesting this cash election must include the shareholder's name and address as they appear on the share certificate. Shareholders with additional questions regarding the Plan or requesting a copy of the terms of the Plan may contact [              ] at [(800)              ].
 
If your shares are held in the name of a broker, bank, or nominee, you should contact such institution. If such institution is not participating in the Plan, your account will be credited with a cash dividend. In order to participate in the Plan through such institution, it may be necessary for you to have your shares taken out of "street name" and re-registered in your own name. Once registered in your own name your dividends will be automatically reinvested. Certain brokers participate in the Plan. Shareholders holding shares in "street name" at participating institutions will have dividends automatically reinvested. Shareholders wishing a cash dividend at such institution must contact their broker to make this change.
 
The number of shares of common stock distributed to participants in the Plan in lieu of cash dividends is determined in the following manner. Under the Plan, whenever the market price of the Fund's common stock is equal to or exceeds net asset value at the time shares are valued for purposes of determining the number of shares equivalent to the cash dividends or capital gains distribution, participants are issued shares of common stock valued at the greater of (i) the net asset value as most recently determined or (ii) 95% of the then current market price of the Fund's common stock. The valuation date is the dividend or distribution payment date or, if that date is not a [                      ] trading day, the next trading day. If the net asset value of the common stock at the time of valuation exceeds the market price of the common stock, participants will receive shares from the Fund valued at market price. If the Fund should declare a dividend or capital gains distribution payable only in cash, [ ] will buy common stock in the open market, or on the [  ] or elsewhere, for the participants' accounts, except that [  ] will endeavor to terminate purchases in the open market and cause the Fund to issue shares at net
 

 
 

 
 

asset value if, following the commencement of such purchases, the market value of the common stock exceeds the then current net asset value.
 
The automatic reinvestment of dividends and capital gains distributions will not relieve participants of any income tax which may be payable on such distributions. A participant in the Plan will be treated for federal income tax purposes as having received, on a dividend payment date, a dividend or distribution in an amount equal to the cash the participant could have received instead of shares.
 
Voluntary Cash Purchase Plan
 
The Voluntary Cash Purchase Plan is yet another vehicle for our shareholders to increase their investment in the Fund. In order to participate in the Voluntary Cash Purchase Plan, shareholders must have their shares registered in their own name.
 
Participants in the Voluntary Cash Purchase Plan have the option of making additional cash payments to [                 ] for investments in the Fund's shares at the then current market price. Shareholders may send an amount from $250 to $10,000. [             ] will use these funds to purchase shares in the open market on or about the 1" and 15th of each month. [                   ] will charge each shareholder who participates $0.75, plus a pro rata share of the brokerage commissions. Brokerage charges for such purchases are expected to be less than the usual brokerage charge for such transactions. It is suggested that any voluntary cash payments be sent to [                    [ such that [      ] receives such payments approximately 10 days before the l and 15th of the month. Funds not received at least five days before the investment date shall be held for investment until the next purchase date. A payment may be withdrawn without charge if notice is received by [                           ] at least 48 hours before such payment is to be invested.
 
Shareholders wishing to liquidate shares held at [                    ] must do so in writing or by telephone. Please submit your request to the above mentioned address or telephone number. Include in your request your name, address, and account number. The cost to liquidate shares is $2.50 per transaction as well as the brokerage commission incurred. Brokerage charges are expected to be less than the usual brokerage charge for such transactions.
 
For more information regarding the Automatic Dividend Reinvestment Plan and Voluntary Cash Purchase Plan, brochures are available by calling (914) 921-5070 or by writing directly to the Fund.
 
The Fund reserves the right to amend or terminate the Plan as applied to any voluntary cash payments made and any dividend or distribution paid subsequent to written notice of the change sent to the members of the Plan at least 90 days before the record date for such dividend or distribution. The Plan also may be amended or terminated by [                                           ] on at least 90 days written notice to participants in the Plan.

 
Exhibit (g)


INVESTMENT ADVISORY AGREEMENT



___________, 2015



Gabelli Funds, LLC
One Corporate Center
Rye, New York 10580-1422

Dear Sir:
 
            The Gabelli Go Anywhere Trust (the “ Fund ”), a statutory trust organized under the laws of the state of Delaware, confirms its investment advisory agreement with Gabelli Funds, LLC (the “ Adviser ”), as follows:

1.  Investment Description; Appointment

The Fund desires to employ its capital by investing and reinvesting in investments of the kind and in accordance with the limitations specified in its Agreement and Declaration of Trust, as amended from time to time (the “ Declaration of Trust ”), and in its Registration Statement on Form N-2 under the Investment Company Act of 1940, as amended (the “ 1940 Act ”) as from time to time in effect (the “ Registration Statement ”) and in such manner and to such extent as may from time to time be approved by the Fund’s Board of Trustees.  Copies of the Declaration of Trust and the Registration Statement in their form on the date hereof have been submitted to the Adviser.  The Fund desires to employ and hereby appoints the Adviser to act as its investment adviser and to oversee the administration of all aspects of the Fund’s business and affairs and provide, or arrange for others whom it believes to be competent to provide, certain services as specified in subparagraph (b) below.  The Adviser accepts the appointment and agrees to furnish the services set forth below for the compensation set forth below.  Nothing contained herein shall be construed to restrict the Fund’s right to hire its own employees or to contract for administrative services to be performed by third parties, including but not limited to, the calculation of the net asset value of the Fund’s shares.

2.  Services

(a)           Investment Advice.  Subject to the direction and control of the Fund’s Board of Trustees, the Adviser will (i) act in conformity with the Declaration of Trust, the 1940 Act and the Investment Advisers Act of 1940, as the same may from time to time be amended, (ii) manage the Fund’s assets in accordance with the Fund’s investment
 

 
 

 

 
objective and policies as stated in the Registration Statement, (iii) make investment decisions for the Fund, (iv) exercise all voting rights in respect of the Fund’s assets and (v) place purchase and sale orders on behalf of the Fund.  In rendering those services, the Adviser will provide investment research and supervision of the Fund’s investments and conduct a continual program of investment, evaluation and, if appropriate, sale and reinvestment of the Fund’s assets.  In addition, the Adviser will furnish the Fund with whatever statistical information the Fund may reasonably request with respect to the securities that the Fund may hold or contemplate purchasing.

(b)           Administration.  The specific services to be provided or arranged for by the Adviser for the Fund are (i) maintaining the Fund’s books and records, such as journals, ledger accounts and other records in accordance with applicable laws and regulations to the extent not maintained by the Fund’s custodian, transfer agent or dividend disbursing agent; (ii) initiating all money transfers to the Fund’s custodian and from the Fund’s custodian for the payment of the Fund’s expenses, investments, and dividends; (iii) reconciling account information and balances among the Fund’s custodian, transfer agent, dividend disbursing agent and the Adviser; (iv) providing the Fund, upon request, with such office space and facilities, utilities and office equipment as are adequate for the Fund’s needs; (v) preparing, but not paying for, all reports by the Fund to its shareholders and all reports and filings required to maintain registration and qualification of the Fund’s shares under federal and state law including the updating of the Fund’s Registration Statement, when necessary; (vi) supervising the calculation of net asset value of the Fund’s shares; and (vii) preparing notices and agendas for meetings of the Fund’s shareholders and the Fund’s Board of Trustees as well as minutes of such meetings in all matters required by applicable law to be acted upon by the Board of Trustees.

3.  Brokerage

In executing transactions for the Fund and selecting brokers or dealers, the Adviser will seek best execution.  In doing so, the Adviser will consider all factors it deems relevant including, but not limited to, the breadth of the market in the security, the price of the security, the financial condition and execution capability of the broker or dealer and the reasonableness of any commission for the specific transaction and on a continuing basis.  In selecting brokers or dealers to execute a particular transaction, the Adviser may consider the brokerage and research services provided to the Fund and/or other accounts over which the Adviser or an affiliate of the Adviser exercises investment discretion.

4.  Information Provided to the Fund

The Adviser will keep the Fund informed of developments materially affecting the Fund, and will, on its own initiative, furnish the Fund from time to time with whatever information the Adviser believes is appropriate for this purpose.
 

 
2

 


5.  Standard of Care

The Adviser shall exercise its professional judgment in rendering the services described in paragraphs 2 and 3 above.  The Adviser shall not be liable for any error of judgment or mistake of law or for any loss suffered by the Fund in connection with the matters of which this Agreement relates, provided that nothing in this paragraph shall be deemed to protect or purport to protect the Adviser against any liability to the Fund or to its shareholders to which the Adviser would otherwise be subject by reason of willful misfeasance, bad faith or gross negligence on its part in the performance of its duties or by reason of the Adviser’s reckless disregard of its obligations and duties under this Agreement.

6.  Compensation

In consideration of the services rendered pursuant to this Agreement, the Fund will pay the Adviser, on the first business day of each month, a fee for the previous month at an annual rate equal to a percentage set forth in the fee schedule attached to this agreement as Appendix A of the Fund’s average weekly net assets.  Upon any termination of this Agreement before the end of a month, the fee for such part of that month shall be prorated according to the proportion that such period bears to the full monthly period and shall be payable upon the date of termination of this Agreement.  For the purpose of determining fees payable to the Adviser, the Fund’s average weekly net assets shall be determined at the end of each month on the basis of the Fund’s average net assets for each week during the month.  The assets for each weekly period shall be determined by averaging the net assets at the end of a week with the net assets at the end of the prior week.  The value of the Fund’s average weekly net assets shall be deemed to be the average weekly value of the Fund’s total assets minus the sum of the Fund’s liabilities (such liabilities shall exclude the aggregate liquidation preference of outstanding preferred shares and accumulated dividends, if any, on those shares and the outstanding principal amount of any debt securities the proceeds of which were used for investment purposes, plus accrued and unpaid interest thereon).

7.  Expenses

The Adviser will bear all expenses in connection with the performance of its services under this Agreement. The Fund will bear certain other expenses to be incurred in its operation, including: underwriting compensation and reimbursements in connection with sales of its securities, expenses for legal and independent accountants’ services, costs of printing proxies, stock certificates and shareholder reports, charges of the custodian, any sub-custodian and transfer and dividend paying agent, expenses in connection with the Automatic Dividend Reinvestment and Voluntary Cash Purchase Plan, Securities and Exchange Commission fees, fees and expenses of Trustees who are not officers or employees of the Adviser or its affiliates, compensation and other expenses of officers and employees of the Fund (including, but not limited to, the Chief Compliance Officer, Vice President and Ombudsman) as approved by the Trustees, accounting and pricing costs, membership fees in trade associations, fidelity bond
 

 
3

 

 
coverage for the Fund’s officers and employees, Trustees and officers’ errors and  omissions insurance coverage, interest, brokerage costs, taxes, stock exchange listing fees and expenses, all expenses of computing the Fund’s net asset value per share, including any equipment or services obtained solely for the purpose of pricing shares or valuing the Fund’s investment portfolios, expenses of qualifying the Fund’s shares for sale in various states, preparation of filings with the Securities and Exchange Commission (including but not limited to Form N-PX, Form N-CSR, Form N-SAR and Form N-Q), the costs of third-party services to monitor and recover class action settlement amounts, litigation and other extraordinary or non-recurring expenses, and other expenses properly payable by the Fund.

8.  Services to Other Companies or Accounts

The Fund understands that the Adviser now acts and will continue to act as investment adviser to other investment companies and may act in the future as investment adviser to other investment companies or portfolios, and the Fund has no objection to the Adviser so acting, provided that whenever the Fund and one or more other portfolios of or investment companies advised by the Adviser and its affiliates have available funds for investment, investments suitable and appropriate for each will be allocated in a manner believed to be equitable to each and that whenever the Fund and one or more other portfolios of or investment companies advised by the Adviser and its affiliates desire to dispose of the same assets, such dispositions will be allocated in a manner believed equitable to each.  The Fund recognizes that in some cases this procedure may adversely affect the size of the position obtainable for the Fund.  In addition, the Fund understands that the Adviser’s agents will not devote their full time to the discharge of its duties under this Agreement and nothing contained herein shall be deemed to limit or restrict the right of the Adviser or any affiliate of the Adviser to engage in and devote time and attention to other businesses or to render services of whatever kind or nature.

9.  Indemnity

(a)           The Fund hereby agrees to indemnify the Adviser and each of the Adviser’s Trustees, officers, employees, and agents (including any individual who serves at the Adviser’s request as director, officer, partner, trustee or the like of another corporation) and controlling persons (each such person being an “indemnitee”) against any liabilities and expenses, including amounts paid in satisfaction of judgments, in compromise or as fines and penalties, and counsel fees (all as provided in accordance with applicable corporate law) reasonably incurred by such indemnitee in connection with the defense or disposition of any action, suit or other proceeding, whether civil or criminal, before any court or administrative or investigative body in which he may be or may have been involved as a party or otherwise or with which he may be or may have been threatened, while acting in any capacity set forth above in this paragraph or thereafter by reason of his having acted in any such capacity, except with respect to any matter as to which he shall have been adjudicated not to have acted in good faith in the reasonable belief that his action was in the best interest of the Fund and furthermore, in the case of any criminal proceeding, so long as he had no reasonable cause to believe that
 

 
4

 

 
the conduct was unlawful, provided, however, that (1) no indemnitee shall be indemnified hereunder against any liability to the Fund or its shareholders or any expense of such indemnitee arising by reason of (i) willful misfeasance, (ii) bad faith, (iii) gross negligence, (iv) reckless disregard of the duties involved in the conduct of his position (the conduct referred to in such clauses (i) through (v) being sometimes referred to herein as “disabling conduct”), (2) as to any matter disposed of by settlement or a compromise payment by such indemnitee, pursuant to a consent decree or otherwise, no indemnification either for said payment or for any other expenses shall be provided unless there has been a determination that such settlement or compromise is in the best interests of the Fund and that such indemnitee appears to have acted in good faith in the reasonable belief that his action was in the best interest of the Fund and did not involve disabling conduct by such indemnitee and (3) with respect to any action, suit or other proceeding voluntarily prosecuted by any indemnitee as plaintiff, indemnification shall be mandatory only if the prosecution of such action, suit or other proceeding by such indemnitee was authorized by a majority of the full Board of the Fund. Notwithstanding the foregoing the Fund shall not be obligated to provide any such indemnification to the extent such provision would waive any right which the Fund cannot lawfully waive.

(b)           The Fund shall make advance payments in connection with the expenses of defending any action with respect to which indemnification might be sought hereunder if the Fund receives a written affirmation of the indemnitee’s good faith belief that the standard of conduct necessary for indemnification has been met and a written undertaking to reimburse the Fund unless it is subsequently determined that he is entitled to such indemnification and if the Trustees of the Fund determine that the facts then known to them would not preclude indemnification. In addition, at least one of the following conditions must be met: (A) the indemnitee shall provide a security for his undertaking, (B) the Fund shall be insured against losses arising by reason of any lawful advances, or (C) a majority of a quorum of Trustees of the Fund who are neither “interested persons” of the Fund (as defined in Section 2(a)(19) of the Act) nor parties to the proceeding (“Disinterested Non-Party Trustees”) or an independent legal counsel in a written opinion, shall determine, based on a review of readily available facts (as opposed to a full trial-type inquiry), that there is reason to believe that the indemnitee ultimately will be found entitled to indemnification.

(c)           All determinations with respect to indemnification hereunder shall be made (1) by a final decision on the merits by a court or other body before whom the proceeding was brought that such indemnitee is not liable by reason of disabling conduct or, (2) in the absence of such a decision, by (i) a majority vote of a quorum of the Disinterested Non-party Trustees of the Fund, or (ii) if such a quorum is not obtainable or even, if obtainable, if a majority vote of such quorum so directs, independent legal counsel in a written opinion.

The rights accruing to any indemnitee under these provisions shall not exclude any other right to which he may be lawfully entitled.

10.  Use of the Word “Gabelli”
 

 
5

 


It is understood and agreed that the word “Gabelli” is the Adviser’s property for copyright and other purposes.  The Fund further agrees that the word “Gabelli” in its name is derived from the name of Mario J. Gabelli and such name may freely be used by the Adviser for other investment companies, entities or products.  The Fund further agrees that, in the event that the Adviser shall cease to act as an investment adviser to the Fund, the Fund shall promptly take all necessary and appropriate action to change its name to one that does not include the word “Gabelli”; provided, however, that the Fund may continue to use such name if the Adviser consents in writing to such use.

11.  Term of Agreement

This Agreement shall become effective, if it has been approved by the Board of Trustees and the sole shareholder or the shareholders of the Fund in accordance with the requirements of the 1940 Act, on the day the Fund commences operations and will continue in effect for two years and thereafter will continue for successive annual periods, provided such continuance is specifically approved at least annually in accordance with the requirements of the 1940 Act. This Agreement is terminable, without penalty, on 60 days written notice by the Fund’s Board of Trustees, by vote of holders of a majority of the Fund’s shares, or by the Adviser. This Agreement will also terminate automatically in the event of its assignment (as defined in the 1940 Act and the rules thereunder).

12.           Amendment

The Adviser and the Fund may amend this Agreement without shareholder approval so long as such amendment does not materially change the advisory relationship between the Adviser and the Fund.
 

 
6

 


If the foregoing is in accordance with your understanding, kindly indicate your acceptance of this Agreement by signing and returning the enclosed copy.

 
Very truly yours,
       
       
 
THE GABELLI GO ANYWHERE TRUST
       
 
By:
   
     
Name:
     
Title:
       
 
Agreed to and Accepted:
       
 
GABELLI FUNDS, LLC
       
 
By:
   
     
Name:
     
Title:



 
7

 

 
APPENDIX A

FEE SCHEDULE

The following percentage shall apply for the purpose of calculating the Adviser’s fee under section 6 of the Investment Advisory Agreement:

1.00% from the commencement of investment operations by the Fund.
 
 
 
 
8



Exhibit (h)(i)










 
The Gabelli Go Anywhere Trust




 
DISTRIBUTION AGREEMENT
 

 
[       ] Common Shares of Beneficial Interest, Par Value $0.001 Per Share
 
 and
 
[            ] Series A Cumulative Puttable and Callable Preferred Shares, Par Value $0.001 Per Share




 



 
 

 

 

DISTRIBUTION AGREEMENT

_________________, 2015

G.research, Inc.
One Corporate Center
Rye, New York 10580

Ladies and Gentlemen:

The Gabelli Go Anywhere Trust (the “ Fund ”), a statutory trust organized and existing under and by virtue of the laws of the State of Delaware, proposes to issue and sell (the “ Offering ”) through G.research, Inc. (the “ Distributor ”), as agent, as many as [          ] common shares of beneficial interest, par value $0.001 (the “ Common Shares ”), and [        ] Series A Cumulative Puttable and Callable Preferred Shares, par value $0.001 (the “ Preferred Shares ,” and together with the Common Shares, the “ Shares ”), to be offered in combinations each consisting of three Common Shares and one Preferred Share (the “ Combinations ”). The term “ Maximum Amount ” shall refer to the total number of Shares registered for sale pursuant to the Registration Statement (as defined below).
 
The Fund has filed, in accordance with the provisions of the Securities Act of 1933, as amended, and the rules and regulations thereunder (collectively called the “ Securities Act ”), and with the provisions of the Investment Company Act of 1940, as amended, and the rules and regulations thereunder (collectively called the “ Investment Company Act ”), with the Securities and Exchange Commission (the “ Commission ”) a registration statement on Form N-2  (File Nos. 333-202459 and 811-23035), including a prospectus and a statement of additional information, relating to the Shares.  In addition, the Fund has filed a Notification of Registration on Form N-8A (the “ Notification ”) pursuant to Section 8 of the Investment Company Act.

The Fund has prepared and filed, in accordance with Section 12 of the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (collectively, the “ Exchange Act ”), and the Commission has declared effective, a registration statement (as amended, the “ Exchange Act Registration Statement ”) on Form 8-A (File No. 001-[  ]) under the Exchange Act to register, under Section 12(b) of the Exchange Act, the Common Shares, the Preferred Shares and the Combinations.

Except where the context otherwise requires, “ Registration Statement ,” as used herein, means the Fund’s registration statement (File Nos. 333-202459 and 811-23035) on Form N-2, as amended (if applicable), at the time it became effective for purposes of Section 11 of the Securities Act, as such section applies to the Distributor (the “ Effective Time ”), including information included in the Prospectus that was omitted from the Registration Statement at the time it became effective but that is deemed to be a part of the Registration Statement at the time it became effective pursuant to Rule 430A (the

 
2

 

Rule 430A Information ”); provided that, if a Rule 462(b) Registration Statement is filed with the Commission, then the term “ Registration Statement ” shall also include such Rule 462(b) Registration Statement. “ Rule 462(b) Registration Statement ” means a registration statement filed by the Fund pursuant to Rule 462(b) for the purpose of registering any of the Common Shares, Preferred Shares or Combinations under the Securities Act, including the Rule 430A Information.

Except where the context otherwise requires, “ Prospectus ,” as used herein, means the final prospectus (including the statement of additional information incorporated therein by reference) relating to the Offering contemplated by this Distribution Agreement, as amended or supplemented from time to time, and as filed by the Fund with the Commission pursuant to Rule 497 under the Securities Act, in the form furnished by the Fund to the Distributor for its use in connection with the Offering.

Sales Materials ” means those advertising materials, sales literature or other promotional materials or documents, if any, constituting an advertisement pursuant to Rule 482 under the Securities Act authorized or prepared by the Fund or authorized or prepared on behalf of the Fund by the Investment Adviser (as defined below) or any representative thereof for use in connection with the Offering; provided , however , that Sales Materials do not include any slides, tapes or other materials or documents that constitute a “written communication” (as defined in Rule 405 under the Securities Act) used in connection with a “road show” or a “bona fide electronic road show” (each as defined in Rule 433 under the Securities Act) related to the Offering contemplated hereby (collectively, “ Road Show Materials ”).

Applicable Time ” means the time as of which this Distribution Agreement was entered into, which shall be 9:00 A.M. (New York City time) on the date of this Distribution Agreement (or such other time as is agreed to by the Fund and the Distributor).

Gabelli Funds, LLC, a New York limited liability company (the “ Investment Adviser ”), acts as the Fund’s investment adviser pursuant to an Investment Advisory Agreement by and between the Fund and the Investment Adviser, dated as of [   ], 2015 (the “ Investment Advisory Agreement ”).  [   ] acts as the custodian (the “ Custodian ”) of the Fund’s cash and portfolio assets pursuant to the Custodian Services Agreement, dated as of [], 2015 (the “ Custodian Agreement ”).  [] acts as the Fund’s transfer agent, registrar, and dividend disbursing agent (the “ Transfer Agent ”) pursuant to a Transfer Agency Agreement, dated as of [], 2015 (the “ Transfer Agency Agreement ”).  [] acts as the sub-administrator of the Fund pursuant to a Sub-Administration Agreement, dated as of [], 2015 (the “ Sub-Administration Agreement ”). [] (the “ Escrow Agent ”) acts as the escrow agent of the Fund pursuant to an Escrow Agent Agreement, dated as of [], 2015 (the “ Escrow Agent Agreement ”).

As used in this Distribution Agreement, “ business day ” shall mean a day on which the New York Stock Exchange (the “ NYSE ”) is open for trading.  The terms “herein,” “hereof,” “hereto,” “hereinafter” and similar terms, as used in this Distribution
 

 
3

 

Agreement, shall in each case refer to this Distribution Agreement as a whole and not to any particular section, paragraph, sentence or other subdivision of this Distribution Agreement.  The term “or,” as used herein, is not exclusive.

The Fund, the Investment Adviser and the Distributor agree as follows:

1.
Agreement to Act as Distributor .

 
(a)
Upon the basis of the warranties and representations and subject to the terms and conditions herein set forth:

 
(i)
The Fund agrees to issue and sell through the Distributor, as agent, and the Distributor agrees to sell, as agent for the Fund, on a best efforts basis, up to the Maximum Amount of the Shares during the term of this Distribution Agreement on the terms set forth herein.

 
(ii)
The Fund hereby authorizes other soliciting broker-dealers (each a “ Soliciting Dealer ” and collectively, the “ Soliciting Dealers ”) that enter into a Soliciting Dealer Agreement with the Distributor in substantially the form attached hereto as Schedule A, to solicit the sale of Shares.

 
(iii)
The Distributor hereby accepts such agency and distributorship and agrees to use its best efforts to sell the Shares as described in the Registration Statement and Prospectus in amounts (including as Combinations) and at prices as directed by the Fund. The Distributor agrees to sell Shares in accordance with the Securities Act, the Investment Company Act and the Exchange Act, and its customary practice subject to the terms and conditions of this Distribution Agreement, the procedures described in the Registration Statement and the Prospectus.

 
(iv)
The Distributor agrees to be bound by the terms of the Escrow Agent Agreement.

 
(b)
Promptly after the effective date of the Registration Statement, but in no event earlier than June [ ], 2015, the Distributor and the Soliciting Dealers shall commence the Offering of the Shares for cash to the public in jurisdictions in which the Shares, including as Combinations, are registered or qualified for sale or in which such Offering is otherwise permitted. The Distributor and Soliciting Dealers shall cease the Offering of the Shares at 5:00 p.m., New York City time on the Expiration Date (the term “ Expiration Date ” means July [ ], 2015, unless and until the Fund shall, in its sole discretion, have extended the period for which the Offering is open, in which event the term “ Expiration Date ” with respect

 
4

 

 
to the Offering will mean the latest time and date on which the Offering, as so extended by the Fund, will expire).

 
(c)
In rendering the services contemplated by this Distribution Agreement, the Distributor acknowledges that it is not authorized to (i) use any solicitation material other than the Prospectus (as supplemented or amended, if applicable) and the Sales Materials or (ii) to make any representation, oral or written, to any shareholders or prospective shareholders of the Fund that is not contained in the Prospectus (as supplemented or amended, if applicable) or the Sales Materials, in each case unless previously authorized to do so in writing by the Fund.

 
(d)
In rendering the services contemplated by this Distribution Agreement, the Distributor will not be subject to any liability to the Fund or the Investment Adviser or any of its affiliates, for any act or omission on the part of any Soliciting Dealer (except with respect to the Distributor acting in such capacity) or any other person, and the Distributor will not be liable for acts or omissions in performing its obligations under this Distribution Agreement, except for any losses, claims, damages, liabilities and expenses that are finally judicially determined to have resulted primarily from the bad faith, willful misconduct or gross negligence of the Distributor or by reason of the reckless disregard of the obligations and duties of the Distributor under this Distribution Agreement.

 
(e)
The Distributor represents and warrants that it will not represent or imply that the Escrow Agent has investigated the desirability or advisability of investment in the Fund, or has approved, endorsed or passed upon the merits of the Shares or the Fund, nor will it use the name of the Escrow Agent in its capacity as escrow agent in any manner whatsoever in connection with the offer or sale of the Shares other than by acknowledgment that it has agreed to serve as escrow agent.

 
(f)
The Distributor may, if it reasonably believes one of the conditions under Section 9(a) below exists, upon notice to the Fund by telephone (confirmed promptly by telecopy or hand delivery), at any time and from time to time suspend the Offering; provided, however, that such suspension shall not affect or impair the parties’ respective obligations with respect to the Shares sold hereunder prior to the giving of such notice and that such suspension shall last no more than ten (10) business days, at which time the Distributor shall either cease such suspension or notify the Fund that this Distribution Agreement is being terminated pursuant to Section 9 below, subject to the terms and conditions hereof.  The Fund may, upon notice to the Distributor by telephone (confirmed promptly by telecopy or hand delivery), at any time and from time to time suspend the Offering; provided, however, that such suspension shall not affect or

 
5

 

 
impair the parties’ respective obligations with respect to the Shares sold hereunder prior to the giving of such notice.

2.
Solicitation Fees

 
(a)
The Fund agrees to pay the Distributor a solicitation fee equal to 1.00% of the gross sales price per Combination (the “ Solicitation Fee ”) for each Combination sold under this Distribution Agreement as determined by further agreement between the Distributor and the Fund from time to time with respect to particular sales.

 
(b)
The proceeds remaining after deduction of the Solicitation Fee and further deduction for any transaction fees imposed by any governmental or self-regulatory organization in respect to such sale shall constitute the net proceeds to the Fund for such Shares (the “ Net Proceeds ”).

 
(c)
In full payment for the soliciting efforts to be rendered, the Distributor agrees to reallow the entire Solicitation Fee to Soliciting Dealers (the “ Commission ”), where such Soliciting Dealer is so designated on the subscription form.  The Distributor has the same rights as the other Soliciting Dealers with respect to Commissions.  The Distributor agrees to pay the Commissions to the broker-dealer designated on the applicable portion of the subscription form.

 
(d)
Payment to the Distributor by the Fund will be in the form of a wire transfer of same day funds from the Fund or the Escrow Agent to an account or accounts identified by the Distributor.  Such payment will be made on the date on which the Fund issues the Shares after the Expiration Date.  Payment to a Soliciting Dealer will be made by the Distributor to such Soliciting Dealer by check or wire transfer to an address or account identified by such broker-dealer.  Such payments shall be made on or before the tenth business day following the day the Fund issues the Shares after the Expiration Date.

 
(e)
Notwithstanding the foregoing, no Solicitation Fees, payments or amounts whatsoever will be paid to the Distributor under this Section 2 unless or until subscriptions for the purchase of Shares have been accepted by the Fund and the gross proceeds of the Shares sold are received by the Fund.

3.
Submission of Orders .

 
(a)
Those persons who place orders for the purchase of Shares will be instructed by the Distributor or a Soliciting Dealer to make their checks, drafts, wires, Automated Clearing House (ACH) or money orders (collectively, “ Instruments of Payment ”) payable to the order of [“[                 ], Escrow Agent for The Gabelli Go Anywhere Trust,” or a

 
6

 

 
recognizable contraction or abbreviation thereof,] and the Distributor or Soliciting Dealer may instruct such persons to remit their Instruments of Payment directly to the Escrow Agent. If the Distributor or a Soliciting Dealer receives an Instrument of Payment made payable to a party other than the Escrow Agent, or otherwise not conforming to the instructions set forth in the Escrow Agreement, the Distributor or Soliciting Dealer shall return such Instrument of Payment directly to such subscriber in a timely fashion in accordance with applicable law, and if the Escrow Agent receives an Instrument of Payment made payable to a party other than the Escrow Agent, or otherwise not conforming to the instructions set forth in the Escrow Agreement, the Distributor may authorize the Escrow Agent to return such Instrument of Payment directly to such subscriber in a timely fashion in accordance with applicable law.  Instruments of Payment received by the Distributor which conform to the instructions set forth in the Escrow Agreement shall be transmitted for deposit pursuant to one of the methods described in this Section 3.  The Distributor may authorize certain Soliciting Dealers which are “$250,000 broker-dealers” to instruct their customers to make their Instruments of Payment for Shares subscribed for payable directly to the Soliciting Dealer.  In such case, the Soliciting Dealer will collect the proceeds of the subscribers’ Instruments of Payment and issue an Instrument of Payment for the aggregate amount of the subscription proceeds made payable to the order of the Escrow Agent. Instruments of Payment of rejected subscribers will be promptly returned to such subscribers. Transmittal of received investor funds will be made in accordance with the following procedures.

 
(b)
Where, pursuant to a Soliciting Dealer’s internal supervisory procedures, internal supervisory review is conducted at the same location at which subscription documents and Instruments of Payment are received from subscribers, Instruments of Payment will be transmitted by noon Eastern Time of the next business day following receipt by the Soliciting Dealer to the Escrow Agent.

 
(c)
Where, pursuant to a Soliciting Dealer’s internal supervisory procedures, final internal supervisory review is conducted at a different location, Instruments of Payment will be transmitted by 5:00 pm Eastern Time of the next business day following receipt by the Soliciting Dealer to the office of the Soliciting Dealer conducting such final internal supervisory review (the “ Final Review Office ”).  The Final Review Office will in turn transmit by noon Eastern Time of the next business day following receipt at a different location by the Final Review Office such Instruments of Payment to the Escrow Agent.

 
(d)
Instruments of Payment shall be mailed or delivered to the Escrow Agent as follows:
[           ], as escrow agent for

 
7

 


The Gabelli Go Anywhere Trust
[Address]
[Phone]
[Wire Instructions, if permitted]

 
(e)
If requested by the Fund, the Distributor shall obtain, and shall cause the Soliciting Dealers to obtain, from subscribers for the Shares, other documentation reasonably deemed by the Fund to be required under applicable law or as may be necessary to reflect the policies of the Fund.  Such documentation may include, without limitation, subscribers’ written acknowledgement and agreement to the privacy policies of the Fund. Subscriptions will be effective only upon the Fund’s acceptance, and the Fund reserves the right to reject any subscription in whole or in part.

4.
Representations and Warranties of the Fund and the Investment Adviser .  Each of the Fund and the Investment Adviser jointly and severally represents and warrants to the Distributor as of the date of this Distribution Agreement and as of the Expiration Date, as follows:

 
(a)
The Fund meets the requirements for use of Form N-2 under the Securities Act and the Investment Company Act.  At the time the Registration Statement became or becomes effective, the Registration Statement did or will contain all statements required to be stated therein in accordance with and did or will comply in all material respects with the requirements of the Securities Act and the Investment Company Act and did not or will not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make the statements therein not misleading.  From the time the Registration Statement became or becomes effective through the Expiration Date, the Prospectus and the other Sales Materials will not contain an untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the representations and warranties in this subsection shall not apply to statements in or omissions from the Registration Statement, Prospectus or Sales Materials made in reliance upon and in conformity with information relating to the Distributor furnished to the Fund in writing by the Distributor expressly for use in the Registration Statement, Prospectus or other Sales Materials.

 
(b)
The Fund (i) has been duly organized and is validly existing as a statutory trust in good standing under the laws of the State of Delaware, (ii) has full statutory trust power and authority to own, lease and operate its properties and conduct its business as described in the Registration Statement and the Prospectus, (iii) currently maintains all necessary licenses, permits, consents, orders, approvals and other authorizations (collectively, the

 
8

 

 
Licenses and Permits ”) necessary to carry on its business as contemplated in the Prospectus, (iv) has made all necessary filings required under any federal, state, local or foreign law, regulation or rule and (v) is duly qualified to do business and in good standing in each jurisdiction wherein it owns or leases real property or in which the conduct of its business requires such qualification, except where the failure to obtain or maintain such Licenses and Permits, to make such filings or be so qualified and in good standing would not have a material adverse effect upon the Fund’s business, properties, management, prospects, financial position or results of operations.  The Fund has no subsidiaries.

 
(c)
The Fund is duly registered with the Commission under the Investment Company Act as a closed-end, non-diversified management investment company, no order of suspension or revocation of such registration has been issued or proceedings therefor initiated or, to the best of the Fund’s and the Investment Adviser’s knowledge, threatened by the Commission, all required action has been taken by the Fund under the Securities Act and the Investment Company Act to make the public offering and to consummate the issuance of the Shares, and the provisions of the Fund’s certificate of trust, declaration of trust and by-laws, as amended to the date hereof (the “ Organizational Documents ”) comply as to form in all material respects with the requirements of the Investment Company Act.

 
(d)
[          ], the independent registered public accounting firm which certified the financial statements of the Fund set forth or incorporated by reference in the Registration Statement and the Prospectus, is an independent registered public accounting firm as required by the Investment Company Act, the Securities Act and by the rules of the Public Company Accounting Oversight Board.

 
(e)
The financial statements of the Fund, together with the related notes and schedules thereto, set forth or incorporated by reference in the Registration Statement and the Prospectus present fairly in all material respects the financial condition of the Fund as of the dates or for the periods indicated in conformity with generally accepted accounting principles applied on a consistent basis.

 
(f)
The capitalization of the Fund is as set forth in the Registration Statement and the Prospectus.  The Common Shares and Preferred Shares each conform in all material respects to the descriptions in the Prospectus.  All the outstanding Common Shares and Preferred Shares have been duly authorized and are validly issued, fully paid and nonassessable.  The Common Shares and Preferred Shares to be issued and sold in accordance with this Distribution Agreement against payment therefor as provided by this Distribution Agreement have been duly authorized and when issued and delivered will have been validly issued and will be fully paid and

 
9

 

 
nonassessable.  No person is entitled to any preemptive or other similar rights with respect to the Common Shares and Preferred Shares.

 
(g)
This Distribution Agreement has been duly authorized, executed and delivered by the Fund.  Each of the Investment Advisory Agreement, the Custodian Agreement, the Transfer Agency Agreement, the Sub-Administration Agreement, the Escrow Agent Agreement and the Dividend Reinvestment Plan (collectively, all the foregoing agreements set forth in this sentence are the “ Fund Agreements ”), has been duly authorized, executed and delivered by the Fund; each of the Fund Agreements complies with all applicable provisions of the Investment Company Act, the Investment Advisers Act of 1940, as amended (the “ Advisers Act ”) and the rules and regulations under such Acts; and, assuming due authorization, execution and delivery by the other parties thereto, each of the Fund Agreements constitutes a legal, valid, binding and enforceable obligation of the Fund, subject to the qualification that the enforceability of the Fund’s obligations thereunder may be limited by bankruptcy, insolvency, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights, to general principles of equity (regardless of whether enforceability is considered in a proceeding in equity or at law) and, in the case of the Investment Advisory Agreement, to termination under the Investment Company Act.

 
(h)
Neither the issuance of Common Shares and Preferred Shares pursuant to this Offering nor the execution, delivery, performance and consummation by the Fund of any other of the transactions contemplated in this Distribution Agreement and the Fund Agreements, nor the consummation of the transactions contemplated in this Distribution Agreement or in the Registration Statement or the Prospectus, nor the fulfillment of the terms hereof or thereof will conflict with or violate the Organizational Documents, or conflict with, result in a breach or violation of, or constitute a default or an event of default under, or result in the creation or imposition of any lien, charge or encumbrance upon any properties or assets of the Fund under the Organizational Documents, or under the terms and provisions of any material agreement, indenture, mortgage, loan agreement, note, insurance or surety agreement, lease or other instrument to which the Fund is a party or by which it may be bound or to which any of the property or assets of the Fund is subject, nor will such action result in any violation of any order, law, rule or regulation of any court or governmental agency or body having jurisdiction over the Fund or any of its properties.

 
(i)
There is no pending or, to the knowledge of the Fund or the Investment Adviser, threatened action, suit, claim, investigation or proceeding affecting the Fund or to which the Fund is a party before or by any court or governmental agency, authority or body or any arbitrator which might

 
10

 

 
result in any material adverse change in the condition (financial or other), business prospects, net worth or operations of the Fund, or which might materially and adversely affect the properties or assets thereof of a character required to be disclosed in the Registration Statement or the Prospectus or the consummation of the transactions contemplated hereby.

 
(j)
There are no franchises, contracts or other documents of the Fund that are material or otherwise required to be described in the Registration Statement or the Prospectus or to be filed or incorporated by reference as exhibits to the Registration Statement which are not described or filed or incorporated by reference therein as permitted by the Securities Act and the Investment Company Act.

 
(k)
No consent, approval, authorization, notification or order of, or filing with, or the issuance of any license or permit by, any court or governmental agency or body is required for the consummation by the Fund of the transactions contemplated by this Distribution Agreement or the Fund Agreements to be consummated by the Fund, except such as have been obtained under the Investment Company Act, the Securities Act and the Exchange Act, any NYSE rules, or by the Financial Industry Regulatory Authority Inc. (“ FINRA ”).

 
(l)
Prior to their issuance, the Common Shares and the Preferred Shares will have been duly approved for listing, subject to official notice of issuance, on the NYSE, as applicable. Prior to their offering, Combinations will have been duly approved for listing, subject to official notice of issuance, on the NYSE.

 
(m)
The Fund (A) has not taken, directly or indirectly, any action designed to cause or to result in, or that has constituted or which might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Fund to facilitate the issuance of the Common Shares or the Preferred Shares or the sale of Combinations, (B) has not since the filing of the Registration Statement sold, bid for or purchased, or paid anyone any compensation for soliciting purchases of, Common Shares or Preferred Shares of the Fund and (C) will not, until the later of the expiration of the Offering (within the meaning of the anti-manipulation rules under the Exchange Act), sell, bid for or purchase, pay or agree to pay to any person any compensation for soliciting another to purchase any other securities of the Fund; provided that any action in connection with the Fund’s automatic dividend reinvestment and voluntary cash purchase plan will not be deemed to be within the terms of this Section 4(m).

 
(n)
The Fund intends to direct the investment of the proceeds of the offering described in the Registration Statement and the Prospectus in such a manner as to comply, with the requirements of Subchapter M of the

 
11

 

 
Internal Revenue Code of 1986, as amended (“ Subchapter M of the Code ”), and intends to qualify as a regulated investment company under Subchapter M of the Code.

 
(o)
The Fund intends to direct the investment of the proceeds of the offering described in the Registration Statement and the Prospectus in such a manner as to comply, with the asset coverage and other applicable requirements of the Investment Company Act.

 
(p)
The Fund has (a) appointed a Chief Compliance Officer and (b) adopted and implemented written policies and procedures which the Board of Trustees of the Fund has determined are reasonably designed to prevent violations of the federal securities laws in a manner required by and consistent with Rule 38a-1 of the rules and regulations under the Investment Company Act and is in compliance in all material respects with such Rule.

 
(q)
The Sales Materials comply with in all material respects the requirements of the Securities Act, the Investment Company Act and the rules and interpretations of FINRA.  Other than the Sales Materials, the Fund has not, without the written permission of the Distributor, used, approved, prepared or authorized any letters from the Fund to securities dealers, commercial banks and other nominees or any newspaper announcements or other offering materials and information in connection with the Offering; provided, however, that any use of transmittal documentation and subscription documentation independently prepared by the Distributor, broker-dealers, trustees, nominees or other financial intermediaries shall not cause a violation of this section 4(q).

 
(r)
Any Sales Materials authorized in writing by or prepared by the Fund or the Investment Adviser used in connection with the issuance of the Shares does not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.

 
(s)
The Fund maintains a system of internal accounting controls sufficient to provide reasonable assurance that (A) transactions are executed in accordance with management’s general or specific authorization; (B) transactions are recorded as necessary to permit preparation of financial statements in conformity with U.S. generally accepted accounting principles and to maintain accountability for assets; (C) access to assets is permitted only in accordance with management’s general or specific authorization; and (D) the recorded accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences.

 
12

 


 
(t)
The Fund has established and maintains disclosure controls and procedures; such disclosure controls and procedures (as such term is defined in Rule 30a-3 under the Investment Company Act) are designed to ensure that material information relating to the Fund is made known to the Fund’s Chief Executive Officer and its Chief Financial Officer, or any other persons of similar title, by others within the Fund, and such disclosure controls and procedures are effective to perform the functions for which they were established; the Fund’s independent registered public accounting firm and the Audit Committee of the Board of Trustees of the Fund have been advised of: (A) any significant deficiencies in the design or operation of internal controls over financial reporting which could adversely affect the Fund’s ability to record, process, summarize, and report financial data; and (B) any fraud, whether or not material, that involves management or other employees who have a role in the Fund’s internal controls over financial reporting; any material weaknesses in the Fund’s internal controls over financial reporting have been identified for the Fund’s independent registered public accounting firm; and since the date of the most recent evaluation of such disclosure controls and procedures, there have been no significant changes in internal controls over financial reporting or in other factors that could materially affect internal controls over financial reporting, including any corrective actions with regard to significant deficiencies and material weaknesses.

 
(u)
The Fund and its officers and trustees, in their capacities as such, are in compliance in all material respects with the applicable provisions of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated thereunder.

 
(v)
Except as disclosed in the Registration Statement and the Prospectus (or any amendment or supplement to any of them), to the Fund’s knowledge, after due inquiry, no trustee of the Fund is an “interested person” (as defined in the Investment Company Act) of the Fund or an “affiliated person” (as defined in the Investment Company Act) of the Distributor.
 
5.
Representations and Warranties of the Investment Adviser .  The Investment Adviser represents to the Distributor as of the date of this Distribution Agreement and as of the Expiration Date, as follows:

 
(a)
The Investment Adviser has been duly formed and is validly existing as a limited liability company in good standing under the laws of the State of New York, has full power and authority (corporate and other) to own its properties and assets and conduct its business as described in the Registration Statement and the Prospectus, and is duly qualified to do business as a foreign corporation and currently maintains all necessary Licenses and Permits in each jurisdiction wherein it owns or leases real property or in which the conduct of its business requires such

 
13

 

 
qualification, except where the failure to be so qualified would not have a material adverse effect upon the Investment Adviser’s business, properties, financial position or operations.

 
(b)
The Investment Adviser is duly registered as an investment adviser under the Advisers Act, and is not prohibited by the Advisers Act or the Investment Company Act, or the rules and regulations under such Acts, from acting as investment adviser for the Fund as contemplated in the Prospectus and the Investment Advisory Agreement.

 
(c)
This Distribution Agreement has been duly authorized, executed and delivered by the Investment Adviser. Each of the Investment Advisory Agreement and the Sub-Administration Agreement (collectively, all the foregoing agreements set forth in this sentence are the “ Adviser Agreements ”), has been duly authorized, executed and delivered by the Adviser; each of the Adviser Agreements complies with all applicable provisions of the Investment Company Act, the Advisers Act and the rules and regulations under such Acts; and, assuming due authorization, execution and delivery by the other parties thereto, each of the Adviser Agreements constitutes a legal, valid, binding and enforceable obligation of the Adviser, subject to the qualification that the enforceability of the Adviser’s obligations thereunder may be limited by bankruptcy, insolvency, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights, to general principles of equity (regardless of whether enforceability is considered in a proceeding in equity or at law) and, in the case of the Investment Advisory Agreement, to termination under the Investment Company Act.

 
(d)
Neither the execution, delivery, performance and consummation by the Investment Adviser of its obligations under this Distribution Agreement or the Adviser Agreements, nor the consummation of the transactions contemplated herein or therein or in the Registration Statement or Prospectus, nor the fulfillment of the terms thereof will conflict with or violate the certificate of formation, limited liability company agreement, by-laws or similar organizational document of the Investment Adviser, as amended to the date hereof, or conflict with, result in a breach or violation of, or constitute a default or an event of default under, or result in the creation or imposition of any lien, charge or encumbrance upon any properties or assets of the Investment Adviser under its certificate of formation, limited liability company agreement, by-laws or similar organizational document, as amended to the date hereof, the terms and provisions of any material agreement, indenture, mortgage, loan agreement, note, insurance or surety agreement, lease or other instrument to which the Investment Adviser is a party or by which it may be bound or to which any of the property or assets of the Investment Adviser is subject, nor will such action result in any violation of any order, law, rule or

 
14

 

 
regulation of any court or governmental agency or body having jurisdiction over the Investment Adviser or any of its properties.

 
(e)
There is no pending or, to the best of the Investment Adviser’s knowledge, threatened action, suit or proceeding affecting the Investment Adviser or to which the Investment Adviser is a party before or by any court or governmental agency, authority or body or any arbitrator which would disqualify the Investment Adviser pursuant to Section 9(a) of the Investment Company Act from acting as investment adviser to the Fund or is otherwise reasonably likely to result in any material adverse change in the Investment Adviser’s ability to perform its services under the Investment Advisory Agreement.

 
(f)
No consent, approval, authorization, notification or order of, or filing with, or the issuance of any license or permit by, any court or governmental agency or body is required for the consummation by the Investment Adviser of the transactions contemplated by this Distribution Agreement or the Investment Advisory Agreement to be consummated by the Investment Adviser except such as have been obtained under the Investment Company Act, the Securities Act, the Exchange Act, any NYSE rules, or by FINRA.

 
(g)
The Investment Adviser (A) has not taken, directly or indirectly, any action designed to cause or to result in, or that has constituted or which might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Fund to facilitate the issuance of the Common Shares or the Preferred Shares or the sale of Combinations, (B) has not since the filing of the Registration Statement sold, bid for or purchased, or paid anyone any compensation for soliciting purchases of, Common Shares or Preferred Shares of the Fund and (C) will not, until the later of the expiration of the Offering (within the meaning of the anti-manipulation rules under the Exchange Act), sell, bid for or purchase, pay or agree to pay any person any compensation for soliciting another to purchase any other securities of the Fund; provided that any action in connection with the Fund’s dividend reinvestment and cash purchase plan will not be deemed to be within the terms of this Section 5(g).

6.
Other Agreements .

 
(a)
The Fund represents to, and covenants with, the Distributor as follows:

 
(i)
The Fund has prepared and filed with the Commission a Registration Statement on Form N-2 for registration under the Securities Act of the Offering. Such Registration Statement, including any amendments thereto filed prior to the time this

 
15

 

 
Distribution Agreement is executed, has or will become effective prior to the Offering. The Fund may file, as part of an amendment to the Registration Statement or pursuant to Rule 497, one or more amendments thereto. The Fund will file with the Commission a final Prospectus (including any statement of additional information incorporated by reference therein) related to the securities subject to the Offering in accordance with Rule 497. As filed, such final Prospectus (including any statement of additional information incorporated by reference therein) shall contain all information required by the Investment Company Act and the Securities Act and shall be in all substantive respects in the form furnished to the Distributor prior to the time this Distribution Agreement is executed or, to the extent not completed at the time this Distribution Agreement is executed, shall contain only such specific additional information and other changes (beyond that contained in any preliminary prospectus) as the Fund has advised the Distributor, prior to the time this Distribution Agreement is executed, will be included or made therein.

 
(ii)
On the effective date, the Registration Statement did, and when the Prospectus is first filed in accordance with Rule 497, the Prospectus (and any supplements thereto) will, comply in all material respects with the applicable requirements of the Securities Act, the Investment Company Act and the Exchange Act; on the effective date and at the time this Distribution Agreement is executed, the Registration Statement will not contain any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary in order to make the statements therein not misleading; and on the date of any filing pursuant to Rule 497, the Prospectus (together with any supplement thereto) will not include any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading; provided, however, that the Fund makes no representations or warranties as to the information contained in or omitted from the Registration Statement, or the Prospectus (or any supplement thereto), in reliance upon and in conformity with information furnished in writing to the Fund by or on behalf of the Distributor specifically for inclusion in the Registration Statement or the Prospectus (or any supplement thereto). The Commission has not issued any order preventing or suspending the use of the Prospectus.

 
(iii)
The Fund will, without charge, deliver to the Distributor, as soon as practicable, the number of copies (one of which is manually executed) of the Registration Statement as originally filed and of

 
16

 

 
each amendment thereto as it may reasonably request, in each case with the exhibits filed therewith.

 
(iv)
The Fund will, without charge, furnish to the Distributor, from time to time during the period when the Prospectus is required to be delivered under the Securities Act, such number of copies of the Prospectus (as amended or supplemented) as the Distributor may reasonably request for the purposes contemplated by the Securities Act.

 
(v)
If any event shall occur as a result of which it is necessary or appropriate, in the reasonable opinion of counsel for the Distributor, to amend or supplement the Registration Statement or the Prospectus (or other Sales Materials) in order to make the Prospectus (or other Sales Materials) not contain an untrue statement of material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein not misleading in the light of the circumstances existing at the time it is delivered, the Fund will forthwith amend or supplement the Prospectus by preparing for filing with the Commission (and furnishing to the Distributor a reasonable number of copies of) an amendment or amendments of the Registration Statement or an amendment or amendments of or a supplement or supplements to the Prospectus (in form and substance reasonably satisfactory to counsel for the Distributor), at the Fund’s expense, which will amend or supplement the Registration Statement or the Prospectus (or otherwise will amend or supplement such other Sales Materials) so that the Prospectus (or such other Sales Materials) will not contain an untrue statement of a material fact or omit to state a material fact required to be stated therein or necessary in order to make the statements therein, in the light of the circumstances existing at the time the Prospectus (or such other Sales Materials) is delivered, not misleading.

 
(vi)
The Fund will endeavor, in cooperation with the Distributor and its counsel, to confirm that the Common Shares and Preferred Shares are not required to be qualified for offering and sale under the applicable securities laws of such states and other jurisdictions of the United States as the Distributor may designate.

 
(vii)
The Fund will make generally available to its security holders as soon as practicable, but no later than 60 days after the end of the Fund’s fiscal semi-annual or fiscal year-end period covered thereby, an earnings statement (which need not be audited) (in form complying with the rules and regulations of the Securities Act) covering a twelve-month period beginning not later than the

 
17

 

 
first day of the Fund’s fiscal semi-annual period next following the effective date of the Registration Statement.

 
(viii)
The Fund will use the net proceeds from the Offering as set forth under “Use of Proceeds” in the Prospectus.

 
(ix)
The Fund will use its best efforts to cause the Common Shares, the Preferred Shares, and the Combinations to be duly authorized for listing by the NYSE, subject to official notice of issuance, prior to the time the Common Shares and Preferred Shares are issued.

 
(x)
The Fund will use its best efforts to maintain its qualification as a regulated investment company under Subchapter M of the Code.
 
 
(xi)
The Fund will apply the net proceeds from the Offering in such a manner as to continue to comply with the requirements of the Prospectus and the Investment Company Act.

 
(b)
Neither the Fund nor the Investment Adviser will take, directly or indirectly, any action designed to cause or to result in, or that has constituted or which might reasonably be expected to constitute, the stabilization or manipulation of the price of any security of the Fund to facilitate the issuance of the Common Shares and the Preferred Shares or the sale of Combinations.

 
(c)
Except as required by applicable law, the use of any reference to the Distributor in any Sales Materials or any other document or communication prepared, approved or authorized by the Fund or the Investment Adviser in connection with the Offering is subject to the prior approval of the Distributor, provided that if such reference to the Distributor is required by applicable law, the Fund and the Investment Adviser agree to notify the Distributor within a reasonable time prior to such use but the Fund and the Investment Adviser are nonetheless permitted to use such reference.

7.
Payment of Expenses .

 
(a)
The Fund will pay all expenses incident to the performance of its obligations under this Distribution Agreement and in connection with the Offering, including, but not limited to, expenses relating to (i) the printing and filing of the Registration Statement as originally filed and of each amendment thereto, (ii) the preparation, issuance and delivery subscription certificates relating to the Shares, (iii) the fees and disbursements of the Fund’s counsel (including the fees and disbursements of local counsel) and accountants, (iv) the printing or other production and delivery to the Distributor of copies of the Registration Statement as originally filed and of each amendment thereto and of the Prospectus and any amendments or

 
18

 

 
supplements thereto, (v) the printing or other production, mailing and delivery expenses incurred in connection with Sales Materials, including all reasonable out-of-pocket fees and expenses, if any, incurred by the Distributor and other brokers, dealers and financial institutions in connection with their customary mailing and handling of materials related to the Offering to their customers, (vi) the fees and expenses incurred in connection with listing the Common Shares, Preferred Shares and Combinations on the NYSE; (vii) the fees and expenses incurred with respect to the Escrow Agent and (viii) all other fees and expenses (excluding the announcement, if any, of the Offering in The Wall Street Journal) incurred in connection with or relating to the Offering.  The Fund agrees to pay the foregoing expenses whether or not the transactions contemplated under this Distribution Agreement are consummated.  To the extent that the foregoing costs and expenses incidental to the performance of the obligations of the Fund under this Distribution Agreement exceed $[          ] per Common Share, the Investment Adviser will pay all such costs and expenses.

 
(b)
If this Distribution Agreement is terminated by the Distributor in accordance with the provisions of Section 8 or Section 9(a)(i), 9(a)(ii) or 9(a)(iii), the Fund agrees to reimburse the Distributor for all of its reasonable out-of-pocket expenses incurred in connection with its performance hereunder, including the reasonable fees and disbursements of counsel for the Distributor.  In the event the transactions contemplated hereunder are not consummated for reasons other than as described in the previous sentence, the Fund agrees to pay all of the costs and expenses set forth in Section 7(a) which the Fund would have paid if such transactions had been consummated.

8.
Conditions of the Distributor’s Obligations .  The obligations of the Distributor to sell Shares are subject to the accuracy of the representations and warranties of the Fund and the Investment Adviser in this Distribution Agreement, to the performance by the Fund and the Investment Adviser of their respective obligations under this Distribution Agreement and to each of the following additional conditions:

 
(a)
The Registration Statement must have become effective.  The Prospectus must have been filed in accordance with Rule 497(b), (c) or (h) or a certificate must have been filed in accordance with Rule 497(j), as the case may be, under the Securities Act.

 
(b)
No order suspending the effectiveness of the Registration Statement may be in effect and no proceedings for such purpose may be pending before or, to the knowledge of counsel to the Distributor, threatened by the Commission, and any requests for additional information on the part of the Commission (to be included in the Registration Statement or the

 
19

 

 
Prospectus or otherwise) must be complied with or waived to the reasonable satisfaction of the Distributor.

 
(c)
Subsequent to the respective dates as of which information is given in the Registration Statement and the Prospectus, there shall not have been any change, or any development involving a prospective change, in or affecting the business or properties of the Fund, the effect of which, is, in the judgment of the Distributor, so material and adverse as to make it impractical or inadvisable to proceed with the Offering as contemplated by the Registration Statement and the Prospectus. 

 
(d)
Prior to the Expiration Date, the Fund shall have furnished to the Distributor such further information, certificates and documents as the Distributor may reasonably request.

 
(e)
If any of the conditions specified in this Section 8 shall not have been fulfilled in all material respects when and as provided in this Distributor Agreement or waived by the Distributor , or if any of the opinions and certificates mentioned above or elsewhere in this Distributor Agreement shall not be in all material respects reasonably satisfactory in form and substance to the Distributor  and its counsel, this Distributor Agreement and all obligations of the Distributor hereunder may be canceled at, or at any time prior to, the Expiration Date by the Distributor. Notice of such cancellation shall be given to the Fund in writing or by telephone confirmed in writing. 

9.
Termination of Agreement .

 
(a)
This Distribution Agreement shall be subject to termination in the absolute discretion of the Distributor, by notice given to the Fund prior to the Expiration Date, if prior to such time (i) financial, political, economic, currency, banking or social conditions in the United States shall have undergone any material change the effect of which on the financial markets makes it, in the Distributor’s judgment, impracticable or inadvisable to proceed with the Offering, (ii) there has occurred any outbreak or material escalation of hostilities, terrorist activities or other calamity or crisis the effect of which on the financial markets of the United States is such as to make it, in the Distributor’s judgment, impracticable or inadvisable to proceed with the Offering, (iii) trading in the Common Shares, the Preferred Shares or the Combinations shall have been suspended by the Commission or the NYSE, (iv) trading in securities generally on the NYSE or NASDAQ shall have been suspended or limited or (v) a banking moratorium shall have been declared either by Federal or New York State authorities.

 
20

 


 
(b)
If this Distribution Agreement is terminated pursuant to this Section, such termination shall be without liability of any party to any other party except as provided in Section 7.

10.
Indemnity and Contribution .

 
(a)
Each of the Fund and the Investment Adviser agrees to indemnify, defend and hold harmless the Distributor, its partners, directors and officers, and any person who controls the Distributor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, and the successors and assigns of all of the foregoing persons from and against any loss, damage, expense, liability or claim (including the reasonable cost of investigation) which the Distributor or any such person may incur under the Securities Act, the Exchange Act, the Investment Company Act, the Advisers Act, the common law or otherwise, insofar as such loss, damage, expense, liability or claim arises out of or is based upon any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or in the Registration Statement as amended by any post-effective amendment thereof by the Fund) in a Prospectus (the term Prospectus for the purpose of this Section 10 being deemed to include any preliminary prospectus, any Sales Material, the Prospectus and the Prospectus as amended or supplemented by the Fund), or arises out of or is based upon any omission or alleged omission to state a material fact required to be stated in either such Registration Statement or Prospectus or necessary to make the statements made therein not misleading (with respect to the Prospectus, in light of the circumstances under which they are made), except insofar as any such loss, damage, expense, liability or claim arises out of or is based upon any untrue statement or alleged untrue statement of a material fact contained in and in conformity with information furnished in writing by or on behalf of the Distributor to the Fund or the Investment Advisor expressly for use with reference to the Distributor in such Registration Statement or such Prospectus or arises out of or is based upon any omission or alleged omission to state a material fact in connection with such information required to be stated in such Registration Statement or such Prospectus or necessary to make such information not misleading (with respect to the Prospectus, in light of the circumstances under which they were made).

If any action, suit or proceeding (together, a “ Proceeding ”) is brought against the Distributor or any such person in respect of which indemnity may be sought against the Fund or the Investment Adviser pursuant to the foregoing paragraph, the Distributor or such person shall promptly notify the Fund or the Investment Adviser, as the case may be, in writing of the institution of such Proceeding and the Fund or the Investment Adviser shall assume the defense of such Proceeding, including the employment of counsel reasonably satisfactory to such indemnified party and payment of

 
21

 

all fees and expenses; provided, however, that the omission to so notify the Fund or the Investment Adviser shall not relieve the Fund or the Investment Adviser from any liability which the Fund or the Investment Adviser may have to the Distributor   or any such person or otherwise.  The Distributor or such person shall have the right to employ its or their own counsel in any such case, but the reasonable fees and expenses of such counsel shall be at the expense of the Distributor or of such person unless the employment of such counsel shall have been authorized in writing by the Fund or the Investment Adviser, as the case may be, in connection with the defense of such Proceeding or the Fund or the Investment Adviser shall not have, within a reasonable period of time in light of the circumstances, employed counsel to have charge of the defense of such Proceeding or such indemnified party or parties shall have reasonably concluded that there may be defenses available to it or them which are different from, additional to or in conflict with those available to the Fund or the Investment Adviser (in which case the Fund or the Investment Adviser shall not have the right to direct the defense of such Proceeding on behalf of the indemnified party or parties), in any of which events such fees and expenses shall be borne by the Fund or the Investment Adviser and paid as incurred (it being understood, however, that the Fund or the Investment Adviser shall not be liable for the expenses of more than one separate counsel (in addition to any local counsel) in any one Proceeding or series of related Proceedings in the same jurisdiction representing the indemnified parties who are parties to such Proceeding).  Neither the Fund nor the Investment Adviser shall be liable for any settlement of any Proceeding effected without its written consent but if settled with the written consent of the Fund or the Investment Adviser, the Fund or the Investment Adviser, as the case may be, agrees to indemnify and hold harmless the Distributor and any such person from and against any loss or liability by reason of such settlement.  Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by the second sentence of this paragraph, then the indemnifying party agrees that it shall be liable for any settlement of any Proceeding effected without its written consent if (i) such settlement is entered into more than 60 business days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement and (iii) such indemnified party shall have given the indemnifying party at least 30 days’ prior notice of its intention to settle.  No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened Proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless such settlement includes an unconditional release of such indemnified party from all liability on claims

 
22

 

that are the subject matter of such Proceeding and does not include an admission of fault, culpability or a failure to act, by or on behalf of such indemnified party.

 
(b)
The Distributor agrees to indemnify, defend and hold harmless the Fund and the Investment Adviser, their directors or trustees, as applicable, and officers, and any person who controls the Fund or the Investment Adviser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, and the successors and assigns of all of the foregoing persons from and against any loss, damage, expense, liability or claim (including the reasonable cost of investigation) which, jointly or severally, the Fund or the Investment Adviser or any such person may incur under the Securities Act, the Exchange Act, the Investment Company Act, the Advisers Act, the common law or otherwise, insofar as such loss, damage, expense, liability or claim arises out of or is based upon any untrue statement or alleged untrue statement of a material fact contained in and in conformity with information concerning the Distributor furnished in writing by or on behalf of the Distributor to the Fund or the Investment Adviser expressly for use with reference to the Distributor in the Registration Statement (or in the Registration Statement as amended by any post-effective amendment thereof by the Fund) or in a Prospectus, or arises out of or is based upon any omission or alleged omission to state a material fact in connection with such information required to be stated in such Registration Statement or such Prospectus or necessary to make such information not misleading (with respect to the Prospectus, in light of the circumstances under which they were made).

If any Proceeding is brought against the Fund, the Investment Adviser or any such person in respect of which indemnity may be sought against the Distributor pursuant to the foregoing paragraph, the Fund, the Investment Adviser or such person shall promptly notify the Distributor in writing of the institution of such Proceeding and the Distributor shall assume the defense of such Proceeding, including the employment of counsel reasonably satisfactory to such indemnified party and payment of all fees and expenses; provided, however, that the omission to so notify the Distributor shall not relieve the Distributor from any liability which the Distributor may have to the Fund, the Investment Adviser or any such person or otherwise.  The Fund, the Investment Adviser or such person shall have the right to employ its own counsel in any such case, but the fees and expenses of such counsel shall be at the expense of the Fund, the Investment Adviser or such person, as the case may be, unless the employment of such counsel shall have been authorized in writing by the Distributor in connection with the defense of such Proceeding or the Distributor shall not have, within a reasonable period of time in light of the circumstances, employed counsel to have charge of the defense of such Proceeding or such indemnified party or parties shall have reasonably

 
23

 

concluded that there may be defenses available to it or them, which are different from or additional to or in conflict with those available to the Distributor (in which case the Distributor shall not have the right to direct the defense of such Proceeding on behalf of the indemnified party or parties, but the Distributor may employ counsel and participate in the defense thereof but the fees and expenses of such counsel shall be at the expense of the Distributor), in any of which events such fees and expenses shall be borne by the Distributor and paid as incurred (it being understood, however, that the Distributor shall not be liable for the expenses of more than one separate counsel (in addition to any local counsel) in any one Proceeding or series of related Proceedings in the same jurisdiction representing the indemnified parties who are parties to such Proceeding).  The Distributor shall not be liable for any settlement of any such Proceeding effected without the written consent of the Distributor but if settled with the written consent of the Distributor agrees to indemnify and hold harmless the Fund, the Investment Adviser and any such person from and against any loss or liability by reason of such settlement.  Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel as contemplated by the second sentence of this paragraph, then the indemnifying party agrees that it shall be liable for any settlement of any Proceeding effected without its written consent if (i) such settlement is entered into more than 60 business days after receipt by such indemnifying party of the aforesaid request, (ii) such indemnifying party shall not have reimbursed the indemnified party in accordance with such request prior to the date of such settlement and (iii) such indemnified party shall have given the indemnifying party at least 30 days’ prior notice of its intention to settle.  No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement of any pending or threatened Proceeding in respect of which any indemnified party is or could have been a party and indemnity could have been sought hereunder by such indemnified party, unless such settlement includes an unconditional release of such indemnified party from all liability on claims that are the subject matter of such Proceeding.

 
(c)
If the indemnification provided for in this Section 10 is unavailable to an indemnified party under subsections (a) and (b) of this Section 10 in respect of any losses, damages, expenses, liabilities or claims referred to therein, then each applicable indemnifying party, in lieu of indemnifying such indemnified party, shall contribute to the amount paid or payable by such indemnified party as a result of such losses, damages, expenses, liabilities or claims (i) in such proportion as is appropriate to reflect the relative benefits received by the Fund and the Investment Adviser on the one hand and the Distributor on the other hand from the Offering of the Shares or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is appropriate to reflect not only

 
24

 

 
the relative benefits referred to in clause (i) above but also the relative fault of the Fund and the Investment Adviser on the one hand and of the Distributor on the other in connection with the statements or omissions, which resulted in such losses, damages, expenses, liabilities or claims, as well as any other relevant equitable considerations.  The relative benefits received by the Fund or the Investment Adviser on the one hand and the Distributor on the other shall be deemed to be in the same respective proportions as the total proceeds from the Offering (net of Solicitation Fee but before deducting expenses) received by the Fund and the total Solicitation Fee received by the Distributor, bear to the aggregate public offering price of the Shares.  The relative fault of the Fund and the Investment Adviser on the hand and of the Distributor on the other shall be determined by reference to, among other things, whether the untrue statement or alleged untrue statement of a material fact or omission or alleged omission relates to information supplied by the Fund or the Investment Adviser or by the Distributor and the parties’ relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission.  The amount paid or payable by a party as a result of the losses, damages, expenses, liabilities and claims referred to in this subsection shall be deemed to include any legal or other fees or expenses reasonably incurred by such party in connection with investigating, preparing to defend or defending any Proceeding.
 
 
(d)
The Fund and the Investment Adviser and the Distributor agree that it would not be just and equitable if contribution pursuant to this Section 10 were determined by pro rata allocation or by any other method of allocation that does not take account of the equitable considerations referred to in subsection (c) above.  Notwithstanding the provisions of this Section 10, the Distributor shall not be required to contribute any amount in excess of the fees received by the Distributor.  No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.

 
(e)
Notwithstanding any other provisions in this Section 10, no party shall be entitled to indemnification or contribution under this Distribution Agreement against any loss, claim, liability, expense or damage arising by reason of such person’s willful misfeasance, bad faith, or gross negligence in the performance of its duties hereunder or reckless disregard of such duties and obligations hereunder.  The parties hereto acknowledge that the foregoing provision shall not be construed to impose upon any such parties any duties under this Distribution Agreement other than specifically set forth herein (it being understood that the Distributor has no duty hereunder to the Fund or the Investment Adviser to perform any due diligence investigation).

 
25

 


 
(f)
The indemnity and contribution agreements contained in this Section 10 and the covenants, warranties and representations of the Fund contained in this Distribution Agreement shall remain in full force and effect regardless of any investigation made by or on behalf of the Distributor, its partners, directors or officers or any person (including each partner, officer or director of such person) who controls the Distributor within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, or by or on behalf of the Fund or the Investment Adviser, its directors or officers or any person who controls the Fund or the Investment Adviser within the meaning of Section 15 of the Securities Act or Section 20 of the Exchange Act, and shall survive any termination of this Distribution Agreement or the issuance and delivery of the Shares.  The Fund or the Investment Adviser and the Distributor agree promptly to notify each other of the commencement of any Proceeding against it and, in the case of the Fund or the Investment Adviser, against any of the Fund’s or the Investment Adviser’s directors or officers in connection with the issuance and sale of the Shares, or in connection with the Registration Statement or Prospectus.

 
(g)
The Fund and the Investment Adviser acknowledge that the statements in the Prospectus with respect to solicitation fees and reallowances of solicitation fees under the caption “Plan of Distribution” in the Prospectus, and the statement of the name and principal business address of the Distributor under the caption “Plan of Distribution” in the Prospectus, constitute the only information furnished in writing by or on behalf of the Distributor to the Fund expressly for use with reference to the Distributor in the Registration Statement or in the Prospectus (as amended or supplemented).  The Distributor confirms that these statements are correct in all material respects and were so furnished by or on behalf of the Distributor for use in the Prospectus.

11.
Notices .  All communications hereunder will be in writing and effective only on receipt, and, if sent to the Distributor, will be mailed, delivered or telegraphed and confirmed to G.research, Inc., One Corporate Center, Rye, New York 10580, Attention: Robert Cullen, and, if to the Fund or the Investment Adviser, shall be sufficient in all respects if delivered or sent to the Fund or the Investment Adviser at One Corporate Center, Rye, New York 10580, Attention: Agnes Mullady.

12.
Governing Law; Construction .  This Distribution Agreement will be governed by and construed in accordance with the laws of the State of New York.  The section headings in this Distribution Agreement have been inserted as a matter of convenience of reference and are not a part of this Distribution Agreement.

13.
Submission to Jurisdiction .  Except as set forth below, no claim (a “ Claim ”) which relates to the terms of this Distribution Agreement or the transactions contemplated hereby may be commenced, prosecuted or continued in any court

 
26

 

 
other than the courts of the State of New York located in the City and County of New York or in the United States District Court for the Southern District of New York, which courts shall have jurisdiction over the adjudication of such matters, and each of the Fund and the Investment Adviser consents to the jurisdiction of such courts and personal service with respect thereto. Each of the Fund and the Investment Adviser hereby consents to personal jurisdiction, service and venue in any court in which any Claim arising out of or in any way relating to this Distribution Agreement is brought by any third party against the Distributor or any indemnified party.  Each of the Distributor, the Fund (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) and the Investment Adviser (on its behalf and, to the extent permitted by applicable law, on behalf of its stockholders and affiliates) waives all right to trial by jury in any action, proceeding or counterclaim (whether based upon contract, tort or otherwise) in any way arising out of or relating to this Distributor Agreement.  Each of the Fund and the Investment Adviser agrees that a final judgment in any such action, proceeding or counterclaim brought in any such court shall be conclusive and binding upon the Fund or the Investment Adviser, as the case may be, and may be enforced in any other courts in the jurisdiction of which the Fund or the Investment Adviser is or may be subject, by suit upon such judgment.

14.
Parties at Interest .  The Agreement herein set forth has been and is made solely for the benefit of the Distributor, the Fund, the Investment Adviser and to the extent provided in Section 10 hereof the controlling persons, shareholders, partners, members, trustees, managers, directors and officers referred to in such section, and their respective successors, assigns, heirs, personal representatives and executors and administrators.  No other person, partnership, association or corporation (including a purchaser, as such purchaser, through the Distributor) shall acquire or have any right under or by virtue of this Distribution Agreement.

15.
Counterparts .  This Distribution Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all of which together shall constitute one and the same instrument.

16.
Successors and Assigns .  This Distribution Agreement will inure to the benefit of and be binding upon the parties hereto and their respective successors and will inure to the benefit of the officers and directors and controlling persons referred to in Section 10 hereof, and no other person will have any right or obligation hereunder.

 
27

 


If the foregoing correctly sets forth the understanding among the Fund, the Investment Adviser and the Distributor, please so indicate in the space provided below, whereupon this letter and your acceptance shall constitute a binding agreement among the Fund, the Investment Adviser and the Distributor.


 
Very truly yours,
   
   
   
 
THE GABELLI GO ANYWHERE TRUST
     
 
By: 
 
   
Name: 
 
   
Title:
 
     
     
     
     
     
 
GABELLI FUNDS, LLC
     
 
By: 
 
   
Name: 
 
   
Title:
 



 
The foregoing Distribution Agreement is hereby confirmed and
accepted as of the date first above written.

 
G.RESEARCH, INC.
 
       
 
By: 
   
  Name:     
  Title:     
 


 
28

 

SCHEDULE A

FORM OF SOLICITATION AGREEMENT

 
 
 
 
 
 
 
Schedule A-1
Exhibit (l)

[Letterhead of Skadden, Arps, Slate, Meagher & Flom LLP]


May 12, 2015



The Gabelli Go Anywhere Trust
One Corporate Center
Rye, New York 10580-1422


 
Re:
The Gabelli Go Anywhere Trust —
 
Registration Statement on Form N-2

Ladies and Gentlemen:

We have acted as special counsel to The Gabelli Go Anywhere Trust, a statutory trust (the “Fund”) created under the Delaware Statutory Trust Act, in connection with the issuance and sale by the Fund of up to 4,500,000 of the Fund’s common shares of beneficial interest, par value $0.001 per share (the “Common Shares”), and up to 1,500,000 Series A Cumulative Puttable and Callable Preferred Shares, par value $0.001 per share, and with a liquidation preference of $40.00 per share (the “Series A Preferred Shares,” and collectively with the Common Shares, the “Shares”), to be sold as 1,500,000 combinations (the “Combinations”) consisting of three Common Shares and one Series A Preferred Share.

This opinion is being furnished in accordance with the requirements of Item 25 of the Form N-2 Registration Statement under the Securities Act of 1933 (the “Securities Act”) and the Investment Company Act of 1940 (the “1940 Act”).

In connection with this opinion, we have examined the originals or copies, certified or otherwise identified to our satisfaction, of:

(i)        the notification of registration on Form N-8A (File No. 811-23035) of the Fund (the “1940 Act Notification”) filed with the Securities and Exchange Commission (the “Commission”) under the 1940 Act on March 2, 2015;

(ii)       the Registration Statement on Form N-2 (File Nos. 333-202459 and 811-23035) of the Fund relating to the Shares and the Combinations filed with the Commission on March 3, 2015 under the Securities Act and the 1940 Act, and as amended by Pre-Effective Amendment No. 1 on April 17, 2015 and as proposed to be amended by Pre-Effective

 
 

 

The Gabelli Go Anywhere Trust
May 12, 2015
Page 2


Amendment No. 2 on the date hereof (such Registration Statement, as so amended and proposed to be amended, being hereinafter referred to as the “Registration Statement”);

(iii)      the form of Distribution Agreement (the “Distribution Agreement”) proposed to be entered into between the Fund, as issuer, Gabelli Funds, LLC, as investment adviser to the Fund, and G.research, Inc. (the “Distributor”), filed as an exhibit to the Registration Statement;

(iv)      a copy of the Fund’s Certificate of Trust, as certified by the Secretary of State of the State of Delaware as of May 11, 2015 and as certified by the Secretary of the Fund as of the date hereof;

(v)      a copy of the Fund’s Agreement and Declaration of Trust, dated February 26, 2015 (the “Declaration”), as certified by the Secretary of the Fund as of the date hereof;

(vi)      a copy of the Fund’s By-Laws, as amended and in effect as of the date hereof (the “By-Laws”), as certified by the Secretary of the Fund as of the date hereof;

(vii)     a copy of a form of the Fund’s Statement of Preferences for the Series A Preferred Shares (the “Statement of Preferences”), as certified by the Secretary of the Fund as of the date hereof;

(viii)    certain resolutions adopted by the Board of Trustees of the Fund, adopted on April 23, 2015, relating to the creation, issuance and sale of the Shares as Combinations and related matters, as certified by the Secretary of the Fund as of the date hereof; and

(ix)      a form of certain resolutions proposed to be adopted by the pricing committee established by the Board of Trustees of the Fund relating to the issuance and sale of the Shares as Combinations (the “Pricing Committee Resolutions”), as certified by the Secretary of the Fund as of the date hereof.

We have also examined originals or copies, certified or otherwise identified to our satisfaction, of such records of the Fund and such agreements, certificates and receipts of public officials, certificates of officers or other representatives of the Fund and others, and such other documents as we have deemed necessary or appropriate as a basis for the opinions stated below.

In our examination, we have assumed the genuineness of all signatures including endorsements, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as facsimile, electronic, certified or photostatic copies, and the authenticity of the originals of such copies. As to any facts relevant to the opinions stated herein that we did not independently establish or verify, we have relied upon statements and representations of officers and other representatives of the Fund and others and of public officials.


 
2

 

The Gabelli Go Anywhere Trust
May 12, 2015
Page 3


In making our examination of documents, we have assumed that the parties thereto, other than the Fund, had or will have the power, corporate or other, to enter into and perform all obligations thereunder and have also assumed the due authorization by all requisite action, corporate or other, and execution and delivery by such parties of such documents and the validity and binding effect thereof on such parties.  We have also assumed that the Statement of Preferences and the Pricing Committee Resolutions will be adopted by the pricing committee of the Board of Trustees of the Fund in substantially the form reviewed by us.  We have also assumed that the Distribution Agreement will be executed and delivered in substantially the form reviewed by us and that if a holder of Shares requests a certificate representing such holder’s Shares, such certificate will have been signed manually or by facsimile by an authorized officer of the transfer agent and registrar for the Shares and registered by such transfer agent and registrar.

Members of our firm are admitted to the practice of law in the State of Delaware and we do not express any opinion as to any laws other than the Delaware Statutory Trust Act (the “DSTA”).

Based upon and subject to the foregoing, we are of the opinion that:

1.        the Shares have been duly authorized by all requisite statutory trust action on the part of the Fund under the DSTA; and

2.        when (a) the Registration Statement becomes effective; and (b) the Shares are issued and delivered by the Fund pursuant to the Distribution Agreement against payment of the consideration set forth therein, and duly entered into the share record books of the Fund, the Shares will be validly issued, fully paid and non-assessable.

We hereby consent to the filing of this opinion with the Commission as an exhibit to the Registration Statement. We also consent to the reference to our firm under the caption “Legal Matters” in the Registration Statement. In giving this consent, we do not thereby admit that we are included in the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission.


Very truly yours,
 
/s/ Skadden, Arps, Slate, Meagher & Flom LLP









3
Exhibit (p)

INITIAL PURCHASE AGREEMENT


The Gabelli Go Anywhere Trust (the “Fund”), a Delaware statutory trust, and GAMCO Investors, Inc. (the “Buyer”) hereby agree as follows:

1.  The Fund hereby offers the Buyer and the Buyer hereby purchases 5,085 common shares of beneficial interest of the Fund, par value $0.001 (the “Common Shares”), and 1,695 Series A Cumulative Puttable and Callable Preferred Shares of the Fund, par value $0.001 (the “Series A Preferred Shares,” each combination of three Common Shares and one Series A Preferred Share being referred to herein as a “Combination”), at a price of $99.00 per Combination.  The Common Shares and the Series A Preferred Shares represent the “initial shares” of the Fund.

2.  The Buyer shall wire the amount of $167,805 to the Fund no later than May 7, 2015 in full payment for the Common Shares and Series A Preferred Shares.

3.  The Buyer represents and warrants to the Fund that the Common Shares and Series A Preferred Shares purchased by the Buyer are being acquired for investment purposes and not for the purpose of distribution.

4.  This Agreement has been executed on behalf of the Fund by the undersigned officer of the Fund in his capacity as an officer of the Fund.

5.  This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but such counterparts shall, together, constitute only one instrument.

 
 
 

 

 
IN WITNESS WHEREOF, the parties hereto have executed this Agreement as of the 7th day of May, 2015.



 
THE GABELLI GO ANYWHERE TRUST
 
         
         
 
By:  
/s/ Andrea R. Mango  
   
Na me:  
Andrea R. Mango  
   
Title:
Secretary  
         
         
 
GAMCO INVESTORS, INC.
 
         
         
 
By:  
/s/ Robert S. Zuccaro  
   
Name:  
Robert S. Zuccaro  
   
Title:
Chief Financial Officer  



Exhibit (r)(i)
 
SECTION S
 
Code of Ethics
 
Gabelli Funds, LLC
GAMCO Asset Management Inc.
G.research, Inc.
G.distributors, LLC
Teton Advisors, Inc.
Gabelli Fixed Income LLC
Gabelli Securities, Inc.
 
Each Registered Investment Company or series thereof (each of which is considered to be a Company for this purpose) for which any of the Companies listed above presently or hereafter provides investment advisory or principal underwriting services, other than a money market fund or a fund that does not invest in Securities.
 
 
Introduction
 
This Code of Ethics establishes rules of conduct for persons who are associated with the companies named above or with the registered investment companies for which such companies provide investment advisory or principal underwriter services. The Code governs their personal investment and other investment-related activities.
 
The basic rule is very simple: we all have a fiduciary duty to put the client's interests first. In particular, you are reminded that investment opportunities must be offered first to clients before the firm or staff may act on them. This is one of the important objectives that the procedures set forth in this Code are intended to accomplish. The rest of the rules elaborate this principle. Some of the rules are imposed specifically by law. For example, the laws that govern investment advisers specifically prohibit fraudulent activity, making statements that are not true or that are misleading or omit something that is significant in the context and engaging in manipulative practices. These are general words, of course, and over the years the courts, the regulators and investment advisers have interpreted these words and established codes of conduct for their employees and others who have access to their investment decisions and trading activities. Indeed, the rules obligate investment advisers to adopt written rules that are reasonably designed to prevent the illegal activities described above and must follow procedures that will enable them to prevent such activities.
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-1

 
 
 
The purpose of this Code is to reinforce and enhance the long-standing commitment of the entire firm to the highest standards of ethical business conduct. Our business depends on our reputation for integrity and principled business conduct, and this reputation, in turn, depends on the day-to-day actions of every staff member. Accordingly, we must avoid conflicts of interest, which may occur when your private interests interfere in any way, or even appear to interfere, with the interests of the firm or its clients. A conflict situation can arise when you take actions or have interests that make it difficult for you to perform your work objectively and effectively. Your obligation to conduct the firm's business in an ethical manner includes the ethical handling of actual or apparent conflicts of interest between personal and business relationships, including full disclosure of such conflicts. Each staff member is responsible for conducting himself in a lawful, honest and ethical manner at all times, and in accordance with all laws, rules and regulations applicable to our business, including this Code and all other internal policies and procedures adopted by the firm.
 
This Code is intended to assist the companies in fulfilling their obligations under the law. The first part lays out who the Code applies to, the second part deals with personal investment activities, the third part deals with other sensitive business practices, and subsequent parts deal with reporting and administrative procedures.
 
The Code is very important to the Companies and their staff members. Violations can not only cause the Companies embarrassment, loss of business, legal restrictions, fines, and other punishments, but for staff members, can lead to demotion, suspension, firing, ejection from the securities business, and very large fines.
 
I.
Applicability
 
 
A.
The Code applies to each of the following:
 
 
1.
The Companies named or described at the top of page one of the Code and all entities that are under common management with these Companies or otherwise agree to be subject to the Code ("Affiliates"). A listing of the Affiliates, which is periodically updated, is attached as Exhibit A.
 
 
2.
Any officer, director or employee of any Company, Affiliate or Fund Client (as defined below) whose job regularly involves him in the investment process. This includes the formulation and making of investment recommendations and decisions, the purchase and sale of securities for clients and the utilization of information about investment recommendations, decisions and trades. Due to the manner in which the Companies and the Affiliates conduct their business, every employee
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-2

 
 
 
should assume that he is subject to the Code unless the Compliance Officer specifies otherwise. 1
 
 
3.
With respect to all of the Companies, Affiliates and Fund Clients except G.research, Inc., any natural person who controls any of the Companies, Affiliates or Fund Clients and who obtains information regarding the Companies' or the Affiliates' investment recommendations or decisions. However, a person whose control arises only as a result of his official position with such entity is excluded. Disinterested directors of Fund Clients and Independent Directors, for example, are excluded from coverage under this item.
 
 
4.
With respect to all of the Companies and Fund Clients except G.research, Inc., any director, officer, general partner or person performing a similar function even if he has no knowledge of and is not involved in the investment process. Interested and disinterested directors of Fund Clients and Independent Directors are included in coverage under this item.
 
 
5.
As an exception, the Code does not apply to any director, officer or employee of any Fund Client (such as certain of The Teton Westwood Funds) with respect to which the Companies' services do not involve the formulation or making of investment recommendations or decisions or the execution of portfolio transactions if that person is also a director, officer or employee of any entity that does perform such services (such as Westwood Management Corp.). These individuals are covered by codes of ethics adopted by such entities.
 
 
B.
Definitions
 
 
1.
Access Persons .  The Companies and the persons described in items (A)2 and (A)3 above other than those excluded by item (A)5 above.
 
 
2.
Access Person Account .  Includes all advisory, brokerage, trust or other accounts or forms of direct beneficial ownership in which one or more Access Persons and/or one or more members of an Access Person's immediate family have a substantial proportionate economic interest. Immediate family includes an Access Person's spouse and minor children living with the Access Person. A substantial proportionate economic interest will generally be 10% of the equity in the account in the case of any single Access Person and 25% of the equity in the account in the case of all Access Persons in the aggregate, whichever is first applicable.
________________________
1
Consultants, interns and part-time employees are subject to the restrictions and reporting requirements of personal investment activities promulgated under the Code.
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-3

 
 
 
Investment partnerships and similar indirect means of ownership other than registered investment companies are also treated as accounts.
 
As an exception, accounts in which one or more Access Persons and/or their immediate family have a substantial proportionate interest which are maintained with persons who have no affiliation with the Companies and with respect to which no Access Person has, in the judgment of the Compliance Officer after reviewing the terms and circumstances, any direct or indirect influence or control over the investment or portfolio execution process are not Access Person Accounts.
 
As a further exception, subject to the provisions of Article II(I)7, bona fide market making accounts of G.research, Inc. are not Access Person Accounts.
 
As a further exception, subject to the provisions of Article II(I)7, bona fide error accounts of the Companies and the Affiliates are not Access Person Accounts.
 
 
3.
Affiliated Mutual Funds .  Registered open-end investment companies or series thereof advised or sub-advised by any of the Companies or their Affiliates.
 
 
4.
Associate Portfolio Managers .   Access Persons who are engaged in securities research and analysis for designated Clients or are responsible for investment recommendations for designated Clients but who are not principally responsible for investment decisions with respect to any Client accounts.
 
 
5.
Clients .   Investment advisory accounts maintained with any of the Companies or Affiliates by any person, other than Access Person Accounts. However, Fund Clients covered by item (A)(5) above are considered Client accounts only with respect to employees specifically identified by the Compliance Officer as having regular information regarding investment recommendations or decisions or portfolio transactions for such Fund Clients.
 
 
6.
Companies .   The companies named or described at the top of page one of the Code.
 
 
Revised: August 7, 2014
INTERNAL USE ONLY
 
S-4

 
 
 
 
7.
Compliance Officer .   The persons designated as the compliance officers of the Companies.
 
 
8.
Covered Persons .   The Companies, the Access Persons and the persons described in item (A)4 above.
 
 
9.
Fund Clients . Clients that are registered investment companies or series thereof.
 
 
10.
Independent Directors .  A director of any of the Companies or Affiliates, other than an investment advisor to a Fund Client, who would not be an "interested person" of any of such entities under Section 2(a)(19) of the Investment Company Act of 1940 but for the fact that he serves as such a director and may own beneficially securities of any such entity constituting less than 5% of the voting securities thereof and may be an associated person of or own securities in a broker-dealer or parent company thereof and who does not have any involvement in the day-to-day activities of any of the Companies or Fund Clients.
 
 
11.
Portfolio Managers .  Access Persons who are principally responsible for investment decisions with respect to any Client accounts.
 
 
12.
Security .  Any financial instrument treated as a security for investment purposes and any related instrument such as a futures, forward or swap contract entered into with respect to one or more securities, a basket of or an index of securities or components of securities. However, the term security does not include securities issued by the Government of the United States, bankers' acceptances, bank certificates of deposit, commercial paper and high quality short-term debt instruments, including repurchase agreements, or shares of registered open-end investment companies. Shares of affiliated registered open-end investment companies are not securities but are subject to special rules under this Code.
 
II.
Restrictions on personal investing activities
 
 
A.
Basic Restriction on Investing Activities
 
If a purchase or sale order is pending or under active consideration for any Client account by any Company or Affiliate, neither the same Security nor any related Security (such as an option, warrant, right, futures contract or convertible security) may be bought or sold for any Access Person Account.
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-5

 
 
 
 
B.
Initial Public Offerings
 
No Security or related Security may be acquired in an initial public offering for any Access Person Account.
 
 
C.
Blackout Period
 
No Security may be bought or sold for the account of any Portfolio Manager or Associate Portfolio Manager, including firm proprietary accounts managed by a portfolio manager or associate portfolio manager, during the period commencing seven (7) calendar days prior to and ending seven (7) calendar days after the purchase or sale (or entry of an order for the purchase or sale) of that Security for the account of any Client with respect to which such person has been designated a Portfolio Manager or Associate Portfolio Manager, unless the Client account receives at least as good a price as the account of the Portfolio Manager or Associate Portfolio Manager and the Compliance Officer determines under the circumstances that the Client account has not been adversely affected (including with respect to the amount of such Security able to be bought by the Client account) by the transaction for the account of the Portfolio Manager or Associate Portfolio Manager.
 
In the event that a security is bought or sold for the account of any Portfolio Manager or Associate Portfolio Manager within the Blackout Period at a price that is more advantageous than the price of the same security bought or sold for the account of any client with respect to which such person has been designated a Portfolio Manager or Associate Portfolio Manager, then the price difference advantage of the Portfolio Manager or Associate Portfolio Manager account over the client account will be disgorged, except where such price difference advantage is of a de minimis amount, in which case no violation will be deemed to have occurred. For purposes of the Blackout Period, a de minimis amount is defined as a price difference advantage in an amount of $250 or less per security.
 
 
D.
Short-term Trading and Affiliated Mutual Funds
 
No Security or related Security may, within a 60-day period, be bought and sold or sold and bought at a profit for any Access Person Account if the Security or related Security was held at any time during that period in any Client account.
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-6

 
 
 
No Affiliated Mutual Fund, except the Gabelli U.S. Treasury Money Market Fund and the Gabelli ABC Fund, may be bought and sold within a 60-calendar day period (measured on a last-in first-out basis) for a single Access Person Account. The Gabelli U.S. Treasury Money Market Fund shall be exempt from the 60-calendar day holding period. The ABC Fund shall have a 21-calendar day holding period (measured on a last-in first-out basis).
 
Shares of Affiliated Mutual Funds purchased via automated investments or by reinvestment of dividends or capital gain distributions will not be subject to the 60-day holding period. Shares of Affiliated Mutual Funds held in 401(k) accounts administered by Ascensus (formerly BISYS) will not be subject to the 60-day holding period where the shares were purchased under the following circumstances:
 
 
Shares purchased by reinvestment of dividends or capital gain distributions;
 
Shares purchased in rollover transactions;
 
Shares purchased for automatic contribution election; and
 
Shares purchased for automated account rebalance.
 
 
E.
Derivative Securities
 
Securities that derive their value, at least in part, from an underlying asset (such as options, warrants, rights and futures contracts) may be bought and sold or sold and bought at a profit unless the underlying asset is subject to the restrictions set forth in paragraphs (A), (C), (D) and (I) or the exemptions set forth in paragraph (H).
 
However, rights that were received pro rata with other security holders are exempt from the 60-day hold set forth in paragraph (D).
 
 
F.
Spinoffs
 
Securities that are derived by the creation of an independent company through the sale or distribution of new shares of an existing company or division of a parent company is subject to the restrictions set forth in paragraphs (A), (C), (D) and (I), but exempt from the 60-day hold requirement set forth in paragraph (D) or the exemptions set forth in paragraph (H).
 
 
G.
Exempt Transactions
 
 
Revised: August 7, 2014
INTERNAL USE ONLY
 
S-7

 
 
 
Participation on an ongoing basis in an issuer's dividend reinvestment or stock purchase plan, participation in any transaction over which no Access Person had any direct or indirect influence or control and involuntary transactions (such as mergers, inheritances, gifts, etc.) are exempt from the restrictions set forth in paragraphs (A), (C) and (D) above without case by case pre-clearance under paragraph (I) below.
 
 
H.
Permitted Exceptions
 
Purchases and sales of the following Securities for Access Person Accounts are exempt from the restrictions set forth in paragraphs (A), (C) and the first sentence of paragraph (D) above if such purchases and sales comply with the pre-clearance requirements of paragraph (I) below:
 
 
1.
Publicly traded non-convertible fixed income Securities rated at least "A";
 
 
2.
Publicly traded equity Securities having a market capitalization in excess of $1.0 billion;
 
 
3.
Publicly traded equity Securities having a market capitalization in excess of $500 million if the transaction in question and the aggregate amount of such Securities and any related Securities purchased and sold for the Access Person Account in question during the preceding 60 days does not exceed 100 shares;
 
 
4.
Municipal Securities; and
 
 
5.
Securities transactions that the Compliance Officer concludes are being effected for federal, state or local income tax purposes.
 
In addition, the exercise of rights that were received pro rata with other security holders is exempt.
 
 
I.
Pre-Clearance of Personal Securities Transactions
 
No Security may be bought or sold for an Access Person Account unless: (i) the Access Person obtains prior approval from the Compliance Officer or, in the absence of the Compliance Officer, from the General Counsel of GAMCO Investors, Inc. or a designee; (ii) the approved transaction is completed on the same day approval is received; and (iii) the Compliance Officer or the General Counsel or designee does not rescind such approval prior to execution of the transaction (See paragraph I below for details of the Pre-Clearance Process.)
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-8

 
 
 
 
J.
Private Placements
 
The Compliance Officer will not approve purchases or sales of Securities that are not publicly traded, unless the Access Person provides full details of the proposed transaction (including written certification that the investment opportunity did not arise by virtue of such person's activities on behalf of any Client) and the Compliance Officer concludes, after consultation with one or more of the relevant Portfolio Managers, that the Companies would have no foreseeable interest in investing in such Security or any related Security for the account of any Client.
 
 
K.
Pre-Clearance Process
 
 
1.
No Securities may be purchased or sold for any Access Person Account unless the particular transaction has been approved in writing by the Compliance Officer or, in his absence, the General Counsel of GAMCO Investors, Inc. or their designees. The Compliance Officer or a designee shall review not less frequently than weekly reports from the trading desk (or, if applicable, confirmations from brokers) to assure that all transactions effected for Access Person Accounts are effected in compliance with this Code.
 
 
2.
No Securities may be purchased or sold for any Access Person Account other than through the trading desk of G.research, Inc., unless express permission is granted by the Compliance Officer. Such permission may be granted only on the condition that the third party broker supply the Compliance Officer, on a timely basis, duplicate copies of confirmations of all personal Securities transactions for such Access Person in the accounts maintained with such third party broker and copies of periodic statements for all such accounts.
 
 
3.
A Trading Approval Form, attached as Exhibit B, must be completed and submitted to the Compliance Officer or a designee for approval prior to entry of an order.
 
 
4.
After reviewing the proposed trade, the level of potential investment interest on behalf of Clients in the Security in question and the Companies' restricted lists, the Compliance Officer shall approve (or disapprove) a trading order on behalf of an Access Person as expeditiously as possible. The Compliance Officer will generally approve transactions described in paragraph (G) above unless the Security in question or a related security is on the Restricted List or the Compliance Officer believes for any other reason that the Access Person Account should not trade in such Security at such time.
 
 
Revised: August 7, 2014
INTERNAL USE ONLY
 
S-9

 
 
 
 
5.
Once an Access Person's Trading Approval Form is approved, the form must be forwarded to the trading desk (or, if a third party broker is permitted, to the Compliance Officer) for execution on the same day. If the Access Person's trading order request is not approved, or is not executed on the same day it is approved, the clearance lapses although such trading order request may be resubmitted at a later date.
 
 
6.
In the absence of the Compliance Officer, an Access Person may submit his or her Trading Approval Form to the General Counsel of GAMCO Investors, Inc or a designee. Trading approval for the Compliance Officer must be obtained from the General Counsel, and trading approval for the General Counsel must be obtained from the Compliance Officer or a designee. In no case will the Trading Desk accept an order for an Access Person Account unless it is accompanied by a signed Trading Approval Form.
 
 
7.
The Compliance Officer shall review all Trading Approval Forms, all initial, quarterly and annual disclosure certifications and the trading activities on behalf of all Client accounts with a view to ensuring that all Covered Persons are complying with the spirit as well as the detailed requirements of this Code. The Compliance Officer will review all transactions in the market making accounts of G.research, Inc. and the error accounts of the Companies and the Affiliates in order to ensure that such transactions are bona fide market making or error transactions or are conducted in accordance with the requirements of this Article II.
 
III.
Other investment-related restrictions
 
 
A.
Gifts
 
No Access Person shall accept any gift or other item of more than $100 in value from any person or entity that does business with or on behalf of any Client.
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-10

 
 
 
 
B.
Service As a Director
 
No Access Person shall commence service on the Board of Directors of a publicly traded company or any company in which any Client account has an interest without prior authorization from the Compliance Committee based upon a determination that the Board service would not be inconsistent with the interests of the Clients. The Compliance Committee shall include the senior Compliance Officer of GAMCO Investors, Inc., the General Counsel of GAMCO Investors, Inc. and at least two of the senior executives from among the Companies.
 
IV.
Reports and additional compliance procedures
 
 
A.
Every Covered Person must submit a report (a form of which is appended as Exhibit C) containing the information set forth in paragraph (B) below with respect to transactions in any Security or Affiliated Mutual Fund in which such Covered Person has or by reason of such transaction acquires, any direct or indirect beneficial ownership (as defined in Exhibit D) in the Security, or Affiliated Mutual Fund and with respect to any account established by the Covered Person in which any Securities or Affiliated Mutual Funds were held for the direct or indirect benefit of the Covered Person; provided, however, that:
 
 
1.
a Covered Person who is required to make reports only because he is a director of one of the Fund Clients and who is a "disinterested" director thereof or who is an Independent Director need not make a report with respect to any transactions other than those where he knew or should have known in the course of his duties as a director that any Fund Client has made or makes a purchase or sale of the same or a related Security, or the investment adviser of any such Fund Client has considered causing any Fund Client to purchase or sell the same or a related Security, within 15 days before or after the purchase or sale of such Security or related Security by such director.
 
 
2.
a Covered Person need not make a report with respect to any transaction effected for, and Securities and Affiliated Mutual Funds held in, any account over which such person does not have any direct or indirect influence or control; and
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-11

 
 
 
 
3.
a Covered Person will be deemed to have complied with the requirements of this Article IV insofar as the Compliance Officer receives in a timely fashion duplicate monthly or quarterly brokerage statements or transaction confirmations on which all transactions required to be reported hereunder are described.
 
 
B.
A Covered Person must submit the report required by this Article to the Compliance Officer no later than 30 days after the end of the calendar quarter in which the transaction or account to which the report relates was effected or established, and the report must contain the date that the report is submitted.
 
 
1.
This report must contain the following information with respect to transactions:
 
 
a.
The date of the transaction, the title and number of shares and the principal amount of each Security and Affiliated Mutual Fund involved;
 
 
b.
The nature of the transaction (i.e., purchase, sale or any other type of acquisition or disposition);
 
 
c.
The price at which the transaction was effected; and
 
 
d.
The name of the broker, dealer or bank with or through whom the transaction was effected.
 
 
2.
This report must contain the following information with respect to accounts established:
 
 
The name of the broker, dealer or bank with whom the account was established; and
 
 
The date the account was established.
 
 
C.
Any report submitted to comply with the requirements of this Article IV may contain a statement that the report shall not be construed as an admission by the person making such report that he has any direct or indirect beneficial ownership in the Security or Affiliated Mutual Fund to which the report relates. A person need not make any report under this Article IV with respect to transactions effected for, and Securities, and Affiliated Mutual Funds held in, any account over which the person has no direct or indirect influence or control.
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-12

 
 
 
 
D.
No later than 10 days after beginning employment with any of the Companies or Affiliates or otherwise becoming a Covered Person, each Covered Person (except for a "disinterested" director of the Fund Client or an Independent Director who is required to submit reports under this Article IV solely by reason of being such a director) must submit a report, which must be current as of a date no more than 45 days prior to the date of beginning employment, containing the following information:
 
 
1.
The title, number of shares and principal amount of each Security and Affiliated Mutual Fund in which the Covered Person had any direct or indirect beneficial ownership when the person became a Covered Person;
 
 
2.
The name of any broker, dealer or bank with whom the Covered Person maintained an account in which any Securities and Affiliated Mutual Fund were held for the direct or indirect benefit of the Covered Person as of the date the person became a Covered Person; and
 
 
3.
The date that the report is submitted.
 
The form of such report is attached as Exhibit E.
 
 
E.
Annually each Covered Person must certify that he has read and understood the Code and recognizes that he is subject to such Code. In addition, annually each Covered Person must certify that he has disclosed or reported all personal Securities and Affiliated Mutual Fund transactions required to be disclosed or reported under the Code and that he is not subject to any regulatory disability described in the annual certification form. Furthermore, each Covered Person (except for a "disinterested" director of the Fund Client or an Independent Director who is required to submit reports under this Article IV solely by reason of being such a director) annually must submit a report containing the following information (which information must be current as of a date no more than 45 days before the report is submitted):
 
 
1.
The title, number of shares and principal amount of each Security and Affiliated Mutual Fund in which the Covered Person had any direct or indirect beneficial ownership;
 
 
2.
The name of any broker, dealer or bank with whom the Covered Person maintains an account in which any Securities and Affiliated Mutual Funds are held for the direct or indirect benefit of the Covered Person; and
 
 
3.
The date that the report is submitted.
 
 
Revised: August 7, 2014
INTERNAL USE ONLY
 
S-13

 
 
 
 
The form of such certification and report is attached as Exhibit F.
 
 
F.
At least annually (or quarterly in the case of Items 4 and 5 below), each of the Companies that has a Fund Client or that provides principal underwriting services for a Fund Client shall, together with each Fund Client, furnish a written report to the Board of Directors of the Fund Client that:
 
 
1.
Describes any issues arising under the Code since the last report.
 
 
2.
Certifies that the Companies have developed procedures concerning Covered Persons' personal trading activities and reporting requirements relevant to such Fund Clients that are reasonably necessary to prevent violations of the Code;
 
 
3.
Recommends changes, if any, to the Fund Clients' or the Companies' Codes of Ethics or procedures;
 
 
4.
Provides a summary of any material or substantive violations of this Code by Covered Persons with respect to such Fund Clients which occurred during the past quarter and the nature of any remedial action taken; and
 
 
5.
Describes any material or significant exceptions to any provisions of this
 
 
G.
The Compliance Officer shall notify each employee of any of the Companies or Affiliates as to whether such person is considered to be an Access Person or Covered Person and shall notify each other person that is considered to be an Access Person or Covered Person.
 
V.
Sanctions
 
The Compliance Officer or his designee will review all Trading Approval Forms, all initial, quarterly and annual disclosure certifications and the trading activities on behalf of all client accounts with a view to ensuring that all Covered Persons are complying with the spirit as well as the detailed requirements of the Code.
 
All violations of the Code must be reported to the Chief Compliance Officer for the appropriate registered investment adviser. In addition, if a staff member becomes aware of or suspects a violation of the Code by any other staff member, the violation or suspected violation must be promptly reported to the Chief Compliance Officer or the General Counsel. Staff members may make such reports anonymously, and will not be retaliated against by the firm for reporting conduct that may constitute a violation of the Code.
 
 
Revised: August 7, 2014
INTERNAL USE ONLY
 
S-14

 
 
 
Upon discovering that a Covered Person has not complied with the requirements of this Code, the Chief Compliance Officer or the General Counsel will advise the Board of Directors of the relevant Company or of the relevant Fund Client. whichever is most appropriate under the circumstances, which may impose on that person whatever sanctions the Board deems appropriate, including, among other things, disgorgement of profit, censure, suspension or termination of employment. Material violations of requirements of this Code by employees of Covered Persons and any sanctions imposed in connection therewith shall be reported not less frequently than quarterly to the Board of Directors of any relevant Company or Fund Client, as applicable.
 
The General Counsel will ensure that the Fund Clients and each Gabelli entity that has a Fund Client, furnish a written report to the Board of Directors of each Fund Client, annually or quarterly as required by the Code, containing the information set forth in Section IV(F) of the Code.
 
VI.
Exceptions
 
The Compliance Committee of the Companies reserves the right to decide, on a case-by-case basis, exceptions to any provisions under this Code. Any exceptions made hereunder will be maintained in writing by the Compliance Committee and presented to the Board of Directors of any relevant Fund Client at its next scheduled meeting.
 
VII.
Preservation of documents
 
This Code, a copy of each report by a Covered Person, any written report made hereunder by the Companies or the Compliance Officer, lists of all persons required to make reports, a list of any exceptions, and the reasons therefore, with respect to Article II.B, and any records under Article II.G with respect to purchases pursuant to Article II.H above, shall be preserved with the records of the relevant Company and any relevant Fund Client for the period required by Rule 17j-1.
 
In accordance with the Investment Advisers Act, the following documents also will be preserved:
 
 
A.
Records of all violations of the Code and any action taken as a result of such violation;
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-15

 
 
 
 
B.
Records of all written acknowledgements of receipt of the Code for all Access Persons for a five-year period;
 
 
C.
A list of all staff members who are or have been Access Persons during the past five years; and
 
 
D.
Records of any decision and supporting reasons for approving the acquisition of securities by Access Persons in limited offerings.
 
VIII.
Other laws, rules and statements of policy
 
Nothing contained in this Code shall be interpreted as relieving any Covered Person from acting in accordance with the provision of any applicable law, rule or regulation or any other statement of policy or procedure governing the conduct of such person adopted by the Companies, the Affiliates or the Fund Clients.
 
IX.
Further information
 
If any person has any question with regard to the applicability of the provisions of this Code generally or with regard to any Securities transaction or transactions, he /she should consult the Compliance Officer.
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-16

 

 
EXHIBIT A
LIST OF AFFILIATES OF THE COMPANIES
 
ALCE Partners, L.P.
Darien Associates LLC
Gabelli & Partners, LLC
Gabelli Arbitrage Holdings LLC
Gabelli Associates Fund
Gabelli Associates Fund II, L.P.
Gabelli Associates Limited
Gabelli Associates Limited II E
Gabelli Capital Structure Arbitrage Master, Ltd.
Gabelli Capital Structure Arbitrage, Ltd.
Gabelli Capital Structure Arbitrage, LP
Gabelli Fixed Income, Inc.
Gabelli Fund, LDC
Gabelli Funds, LLC
Gabelli Global Partners Ltd.
Gabelli Global Partners Master, Ltd.
Gabelli Green Long/Short Fund L.P.
Gabelli Green Long/Short Fund Ltd.
Gabelli Intermediate Credit Fund LP
Gabelli Intermediate Credit Fund Ltd.
Gabelli International Gold Fund Limited
Gabelli International Limited
Gabelli Japanese Value Partners Master Fund, Ltd.
Gabelli Japanese Value Partners, LP
Gabelli Multimedia Partners, L.P.
Gabelli Performance Partnership L.P.
Gabelli Securities International Ltd.
Gabelli Trading Holdings LLC
GAMA Capital Opportunities Ltd.
GAMA Capital Opportunities Master Fund Ltd.
GAMA Capital Partners LP
GAMA Select Energy Plus, LP
GAMA Select Energy Plus Master Fund, Ltd.
GAMCO Acquisitions LLC
GAMCO Asset Management (UK) Ltd.
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-17

 
 
 
GAMCO International Partners LLC
GAMCO Investors, Inc.
GAMCO Medical Opportunities, L.P.
Gemini Capital Management LLC
Gemini Capital Management Partners, LP
Gemini Global Partners, LP
GGCP Holdings, LLC
GGCP, Inc.
1B401, Inc.
IB402, Inc.
MJG Associates, Inc.

 
Revised: August 7, 2014
INTERNAL USE ONLY
 
S-18

 


EXHIBIT B
PRE-CLEARANCE TRADING APPROVAL FORM
 
I, ___________________________________ (name), am an Access Person or authorized officer thereof and seek pre-clearance to engage in the transaction described below for the benefit of myself or another Access Person:
 
Acquisition or Disposition (circle one)
 
Name of Account:
   
     
Account Number:
   
     
Date of Request:
   
     
Security:
   
     
Amount or # of Shares:
   
     
Broker:
   
 
If the transaction involves a Security that is not publicly traded, a description of proposed transaction, source of investment opportunity and any potential conflicts of interest:
 
I hereby certify that, to the best of my knowledge, the transaction described herein is not prohibited by the Code of Ethics and that the opportunity to engage in the transaction did not arise by virtue of my activities on behalf of any Client.
 
Signature:  
 
   Print Name:  
 
 
Approved or Disapproved (Circle One)
 
Date of Approval:  
     

Signature:  
 
   Print Name:  
 
 
If approval is granted, please forward this form to the trading desk (or if a third party broker is permitted, to the Compliance Officer) for immediate execution.
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-19

 


EXHIBIT C
TRANSACTION REPORT
 
Report submitted by:
   
   
Print Name
 
This transaction report (the "Report") is submitted pursuant to Section IV (B) of the Code of Ethics of the Companies and supplies information with respect to transactions in any Security or Affiliated Mutual Fund in which you may be deemed to have, or by reason of such transaction acquire, any direct or indirect beneficial ownership interest, and with respect to accounts established by you in which any Securities or Affiliated Mutual Funds were held for your direct or indirect benefit, for the period specified below. If you were not employed by or affiliated with us during this entire period, amend the dates specified below to cover your period of employment or affiliation.
 
Unless the context otherwise requires, all terms used in the Report shall have the same meaning as set forth in the Code of Ethics.
 
If you have no reportable transactions or new accounts, sign and return this page only. If you have reportable transactions or new accounts, complete, sign and return page two only and include any attachments.
 
I HAD NO REPORTABLE SECURITIES OR AFFILIATED MUTUAL FUND TRANSACTIONS OR ACCOUNTS ESTABLISHED DURING THE PREVIOUS CALENDAR QUARTER. I CERTIFY THAT I AM FULLY FAMILIAR WITH THE CODE OF ETHICS AND THAT, TO THE BEST OF MY KNOWLEDGE, THE INFORMATION FURNISHED IN THIS REPORT IS TRUE AND CORRECT.
 
Signature
   
Position
   
Date
   


Revised: August 7, 2014
INTERNAL USE ONLY
 
S-20

 


Page 2
TRANSACTION REPORT
 
Report submitted by:
   
   
Print Name
 
The following tables supply the information required by Section IV (B) of the Code of Ethics for the period specified below. All transactions including transactions in Affiliated Mutual Funds must be listed. Transactions reported on brokerage statements or duplicate confirmations actually received by the Compliance Officer do not have to be listed although it is your responsibility to make sure that such statements or confirmations are complete and have been received in a timely fashion. If you had transactions of the kind described above, you may simply state, "See statements." Consent will be deemed to have been given to the firm to receive duplicate account statements and trade confirmations for all approved outside accounts.
 
TRANSACTIONS
Securities (Name and Symbol)
 
Date of Transaction
 
Whether Purchase, Sale, Short Sale or Other Type of Disposition or Acquisition
 
Quantity of Securities
 
Price per Share of Securities
 
Name of Broker/Dealer with or through Whom the Transaction was Effected
 
Nature of Ownership of Securities


NEW ACCOUNTS ESTABLISHED
Name of Broker, Dealer or Bank
 
Account Number
 
Date Account Established



* To the extent specified above, I hereby disclaim beneficial ownership of any securities listed in this Report or brokerage statements or transaction confirmations provided by me.
 
I CERTIFY THAT I AM FULLY FAMILIAR WITH THE CODE OF ETHICS AND THAT, TO THE BEST OF MY KNOWLEDGE, THE INFORMATION IN THIS REPORT IS TRUE AND CORRECT FOR THE PREVIOUS CALENDAR QUARTER.
 
Signature 
   
Date 
 
         
Position
       
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-21

 

EXHIBIT D
BENEFICIAL OWNERSHIP
 
For purposes of the attached Code of Ethics, "beneficial ownership" shall be interpreted in the same manner as it would be in determining whether a person is subject to the provisions of Section 16 of the Securities Exchange Act of 1934 and the rules and regulations thereunder, except the determination of direct or indirect beneficial ownership shall apply to all securities that a Covered Person has or acquires. The term "beneficial ownership" of securities would include not only ownership of securities held be a Covered Person for his own benefit, whether in bearer form or registered in his name or otherwise, but also ownership of securities held for his benefit by others (regardless of whether or how they are registered) such as custodians, brokers, executors, administrators, or trustees (including trusts in which he has only a remainder interest), and securities held for his account by pledges, securities owned by a partnership in which he is a member if he may exercise a controlling influence over the purchase, sale of voting of such securities, and securities owned by any corporation or similar entry in which he owns securities if the shareholder is a control-ling shareholder of the entity and has or shares investment control over the entity's portfolio.
 
Ordinarily, this term would not include securities held by executors or administrators in estates in which a Covered Person is a legatee or beneficiary unless there is a specified legacy to such person of such securities or such person is the sole legatee or beneficiary and there are other assets in the estate sufficient to pay debts ranking ahead of such legacy, or the securities are held in the estate more than a year after the decedent's death.
 
Securities held in the name of another should be considered as beneficially owned by a Covered Person where such person enjoys "financial benefits substantially equivalent to ownership." The Securities and Exchange Commission has said that, although the final determination of beneficial ownership is a question to be determined in the light of the facts of the particular case, generally a person is regarded as the beneficial owner of securities held in the name of his or her spouse and their minor children. Absent special circumstances such relationship ordinarily results in such person obtaining financial benefits substantially equivalent to ownership, e.g., application of the income derived from such securities to maintain a common home, or to meet expenses that such person otherwise would meet from other sources, or the ability to exercises a controlling influence over the purchase, sale or voting of such securities.
 
A Covered Person also may be regarded as the beneficial owner of securities held in the name of another person, if by reason of any contract, understanding, relationship, agreement, or other agreement, he obtains therefrom financial benefits substantially equivalent to those of ownership.
 
A Covered Person also is regarded as the beneficial owner of securities held in the name of a spouse, minor children or other person, even though he does not obtain therefrom the aforementioned benefits of ownership, if he can vest or revest title in himself at once or at some future time.
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-22

 

EXHIBIT E
INITIAL HOLDINGS REPORT
 
Report submitted by:
   
   
Print Name

This initial holdings report (the "Report") is submitted pursuant to Section IV (D) of the Code of Ethics of the Companies and supplies information with respect to any Security and Affiliated Mutual Fund in which you may be deemed to have any direct or indirect beneficial ownership interest and any accounts established by you in which any Securities or Affiliated Mutual Funds were held for your direct or indirect benefit, as of a date no more than 45 days ago.
 
Unless the context otherwise requires, all terms used in the Report shall have the same meaning as set forth in the Code of Ethics.
 
If you have no reportable Securities, Affiliated Mutual Funds, or accounts, sign and return this page only. If you have reportable Securities, Affiliated Mutual Funds, or accounts, complete, sign and return Page 2 and any attachments.
 

 

 

 

 

 
I HAVE NO REPORTABLE SECURITIES OR AFFILIATED MUTUAL FUND ACCOUNTS AS OF ___________________. I CERTIFY THAT I AM FULLY FAMILIAR WITH THE CODE OF ETHICS AND THAT, TO THE BEST OF MY KNOWLEDGE, THE INFORMATION FURNISHED IN THIS REPORT IS TRUE AND CORRECT.
 
Signature
   
     
Position
   
     
Date
   


Revised: August 7, 2014
INTERNAL USE ONLY
 
S-23

 


Page 2
INITIAL HOLDINGS REPORT
 
Report submitted by:
   
   
Print Name
The following tables supply the information required by Section IV (D) of the Code of Ethics as of the date you became subject to the Code. Include all holdings of Affiliated Mutual Funds. Consent will be deemed to have been given to the firm to receive duplicate account statements and trade confirmations for all approved outside accounts.
 
SECURITIES HOLDINGS
Securities (Name and Symbol)
 
Quantity of Securities
 
Name of Broker/Dealer Where
Securities Are Held
 
Nature of Ownership of Securities




ACCOUNTS ESTABLISHED
Name of Broker, Dealer or Bank
 
Account Number






I CERTIFY THAT I AM FULLY FAMILIAR WITH THE CODE OF ETHICS AND THAT, TO THE BEST OF MY KNOWLEDGE, THE INFORMATION IN THIS REPORT IS TRUE AND CORRECT AS OF ____________________________________________________ .


Signature 
   
Date 
 
         
Position
       
 

Revised: August 7, 2014
INTERNAL USE ONLY
 
S-24

 


EXHIBIT F
ANNUAL CERTIFICATION OF CODE OF ETHICS
 
 
A.
I (a Covered Person) hereby certify that I have read and understood the Code of Ethics, and recognize that I am subject to its provisions. In addition, I hereby certify that I have disclosed or reported all personal transactions in Securities and Affiliated Mutual Funds required to be disclosed or reported under the Code of Ethics;
 
 
B.
Within the last ten years there have been no complaints or disciplinary actions filed against me by any regulated securities or commodities exchange, any self-regulatory securities or commodities organization, any attorney general, or any governmental office or agency regulating insurance, securities, commodities or financial transactions in the United States, in any state of the United States, or in any other country;
 
 
C.
I have not within the last ten years been convicted of or acknowledged commission of any felony or misdemeanor arising out of my conduct as an employee, salesperson, officer, director, insurance agent, broker, dealer, underwriter, investment manager or investment advisor; and
 
 
D.
I have not been denied permission or otherwise enjoined by order, judgment or decree of any court of competent jurisdiction, regulated securities or commodities exchange, self-regulatory securities or commodities organization or other federal or state regulatory authority from acting as an investment advisor, securities or commodities broker or dealer, commodity pool operator or trading advisor or as an affiliated person or employee of any investment company, bank, insurance company or commodity broker, dealer, pool operator or trading advisor, or from engaging in or continuing any conduct or practice in connection with any such activity or the purchase or sale of any security.
 
 
E.
Unless I am exempt from filing an Annual Holdings Report (as a "disinterested" director of a Fund Client or an Independent Director of an Affiliate), I have attached a completed Annual Holdings Report which is accurate as of a date no more than 45 days ago.
 
Print Name
   
     
Signature
   
     
Date
   


Revised: August 7, 2014
INTERNAL USE ONLY
 
S-25

 


Page 2
ANNUAL HOLDINGS REPORT
 
Report submitted by:
   
   
Print Name
The following tables supply the information required by Section IV (E) of the Code of Ethics as of a date no more than 45 days before this report is submitted. All transactions including transactions in Affiliated Mutual Funds must be listed. Transactions reported on brokerage statements or duplicate confirmations actually received by the Compliance Officer do not have to be listed although it is your responsibility to make sure that such statements or confirmations are complete and have been received in a timely fashion. If you had transactions of the kind described above, you may simply state, "See statements." Consent will be deemed to have been given to the firm to receive duplicate account statements and trade confirmations for all approved outside accounts. If you have no reportable Securities or Affiliated Mutual Fund holdings or accounts, write "None" in the space provided.
 
SECURITIES HOLDINGS
Securities (Name and Symbol)
 
Quantity of Securities
 
Name of Broker/Dealer Where
Securities Are Held
 
Nature of Ownership of Securities




ACCOUNTS
Name of Broker, Dealer or Bank
 
Account Number




Signature 
   
Date 
 
         
Position
       


 
 
Revised: August 7, 2014
INTERNAL USE ONLY

S-26
 
 
Exhibit (r)(ii)


Joint Code of Ethics for Chief Executive
and Senior Financial Officers of the Gabelli/GAMCO/TETON Funds
 
 
 
Each affiliated registered investment company (each a “ Company ”) is committed to conducting business in accordance with applicable laws, rules and regulations and the highest standards of business ethics, and to full and accurate disclosure -- financial and otherwise -- in compliance with applicable law. This Code of Ethics, applicable to each Company’s Chief Executive Officer, President, Chief Financial Officer and Treasurer (or persons performing similar functions) (together, “ Senior Officers ”), sets forth policies to guide you in the performance of your duties.
 
As a Senior Officer, you must comply with applicable law. You also have a responsibility to conduct yourself in an honest and ethical manner. You have leadership responsibilities that include creating a culture of high ethical standards and a commitment to compliance, maintaining a work environment that encourages the internal reporting of compliance concerns and promptly addressing compliance concerns.
 
This Code of Ethics recognizes that the Senior Officers are subject to certain conflicts of interest inherent in the operation of investment companies, because the Senior Officers currently or may in the future serve as Senior Officers of each of the Companies, as officers or employees of the investment advisor to the Companies or service providers thereof (the “ Advisor ”) and/or affiliates of the Advisor (the “Advisory Group”) and as officers or trustees/directors of other registered investment companies and unregistered investment funds advised by the Advisory Group. This Code of Ethics also recognizes that certain laws and regulations applicable to, and certain policies and procedures adopted by, the Companies or the Advisory Group govern your conduct in connection with many of the conflict of interest situations that arise in connection with the operations of the Companies, including:
 
 
·
the Investment Company Act of 1940, and the rules and regulation promulgated thereunder by the Securities and Exchange Commission (the “ 1940 Act ”);
 
 
·
the Investment Advisers Act of 1940, and the rules and regulations promulgated thereunder by the Securities and Exchange Commission (the “ Advisers Act ”);
 
 
·
the Code of Ethics adopted by each Company pursuant to Rule 17j-1(c) under the 1940 Act (collectively, the “ Trust’s 1940 Act Code of Ethics ”);
 
 
·
one or more codes of ethics adopted by the Advisory Group that have been reviewed and approved by those trustees/directors (the “ Directors ”) of each Company that are not “interested persons” of such Company (the “ Independent Directors ”) within the meaning of the 1940 Act (the “ Advisory Group’s 1940 Act Code of Ethics ” and, together with such Company’s 1940 Act Code of Ethics, the “ 1940 Act Codes of Ethics ”);
 

Revised: July 30, 2014
 
 
 

 
 

 
·
the policies and procedures adopted by each Company to address conflict of interest situations, such as procedures under Rule 10f-3, Rule 17a-7 and Rule 17e-1 tinder the 1940 Act (collectively, the “ Conflict Policies ”); and
 
 
·
the Advisory Group’s policies and procedures to address, among other things, conflict of interest situations and related matters (collectively, the “ Advisory Policies ”).
 
The provisions of the 1940 Act, the Advisers Act, the 1940 Act Codes of Ethics, the Conflict Policies and the Advisory Policies are referred to herein collectively as the “ Additional Conflict Rules ”.
 
This Code of Ethics is different from, and is intended to supplement, the Additional Conflict Rules. Accordingly, a violation of the Additional Conflict Rules by a Senior Officer is hereby deemed not to be a violation of this Code of Ethics, unless and until the Directors shall determine that any such violation of the Additional Conflict Rules is also a violation of this Code of Ethics.
 
Senior Officers Should Act Honestly and Candidly
 
Each Senior Officer has a responsibility to each Company to act with integrity. Integrity requires, among other things, being honest and candid. Deceit and subordination of principle are inconsistent with integrity.
 
Each Senior Officer must:
 
 
·
act with integrity, including being honest and candid while still maintaining the confidentiality of information where required by law or the Additional Conflict Rules;
 
 
·
comply with the laws, rules and regulations that govern the conduct of each Company’s operations and report any suspected violations thereof in accordance with the section below entitled “Compliance With Code Of Ethics”; and
 
 
·
adhere to a high standard of business ethics.
 
Conflicts Of Interest
 
A conflict of interest for the purpose of this Code of Ethics occurs when your private interests interfere in any way, or even appear to interfere, with the interests of a Company.
 

Revised: July 30, 2014
 
 
2

 

 
Senior Officers are expected to use objective and unbiased standards when making decisions that affect each Company, keeping in mind that Senior Officers are subject to certain inherent conflicts of interest because Senior Officers of a Company also are or may be officers of other Companies and/or the Advisory Group (as a result of which it is incumbent upon you to be familiar with and to seek to comply with the Additional Conflict Rules).
 
You are required to conduct the business of each Company in an honest and ethical manner, including the ethical handling of actual or apparent conflicts of interest between personal and business relationships. When making any investment, accepting any position or benefits, participating in any transaction or business arrangement or otherwise acting in a manner that creates or appears to create a conflict of interest with respect to each Company where you are receiving a personal benefit, you should act in accordance with the letter and spirit of this Code of Ethics.
 
If you are in doubt as to the application or interpretation of this Code of Ethics to you as a Senior Officer of a Company, you should make full disclosure of all relevant facts and circumstances to the Chief Compliance Officer of the Advisory Group (the “ CCO ”) and obtain the approval of the CCO prior to taking action.
 
Some conflict of interest situations that should always be approved by the CCO, if material, include the following:
 
 
·
the receipt of any entertainment or non-nominal gift by the Senior Officer, or a member of his or her family, from any company with which a Company has current or prospective business dealings (other than the Advisory Group), unless such entertainment or gift is business related, reasonable in cost, appropriate as to time and place, and not so frequent as to raise any question of impropriety;
 
 
·
any ownership interest in, or any consulting or employment relationship with, of any of the Companies’ service providers, other than the Advisory Group; or
 
 
·
a direct or indirect financial interest in commissions, transaction charges or spreads paid by a Company for effecting portfolio transactions or for selling or redeeming shares other than an interest arising from the Senior Officer’s employment by the Advisory Group, such as compensation or equity ownership.
 
Disclosures
 
It is the policy of each Company to make full, fair, accurate, timely and understandable disclosure in compliance with all applicable laws and regulations in all reports and documents that such Company files with, or submits to, the Securities and Exchange Commission or a national securities exchange and in all other public communications made by such Company. As a Senior Officer, you are required to promote compliance with this policy and to abide by such Company’s standards, policies and procedures designed to promote compliance with this policy.
 
 
Revised: July 30, 2014
 
 
3

 
 
 
Each Senior Officer must:
 
 
·
familiarize himself or herself with the disclosure requirements applicable to each Company as well as the business and financial operations of each Company; and
 
 
·
not knowingly misrepresent, or cause others to misrepresent, facts about any Company to others, including to the Directors, such Company’s independent auditors, such Company’s counsel, any counsel to the Independent Directors, governmental regulators or self-regulatory organizations.
 
Compliance With Code Of Ethics
 
If you know of or suspect a violation of this Code of Ethics or other laws, regulations, policies or procedures applicable to the Company, you must report that information on a timely basis to the CCO or report it anonymously by following the “whistle blower” policies adopted by the Advisory Group from time to time. No one will be subject to retaliation because of a good faith report of a suspected violation.
 
Each Company will follow these procedures in investigating and enforcing this Code of Ethics, and in reporting on this Code of Ethics:
 
 
·
the CCO will take all appropriate action to investigate any actual or potential violations reported to him or her;
 
 
·
violations and potential violations will be reported to the Board of Directors of each affected Company after such investigation;
 
 
·
if the Board of Directors determines that a violation has occurred, it will take all appropriate disciplinary or preventive action; and
 
 
·
appropriate disciplinary or preventive action may include a letter of censure, suspension, dismissal or, in the event of criminal or other serious violations of law, notification of the Securities and Exchange Commission or other appropriate law enforcement authorities.
 
Waivers Of Code Of Ethics
 
Except as otherwise provided in this Code of Ethics, the CCO is responsible for applying this Code of Ethics to specific situations in which questions are presented to the CCO and has the authority to interpret this Code of Ethics in any particular situation. The CCO shall take all action he or she considers appropriate to investigate any actual or potential violations reported under this Code of Ethics.
 

Revised: July 30, 2014
 
 
4

 

The CCO is authorized to consult, as appropriate, with counsel to the affected Company, the Advisory Group or the Independent Directors, and is encouraged to do so.
 
The Board of Directors of the affected Company is responsible for granting waivers of this Code of Ethics, as appropriate. Any changes to or waivers of this Code of Ethics will, to the extent required, be disclosed on Form N-CSR, or otherwise, as provided by Securities and Exchange Commission rules.
 
Recordkeeping
 
Each Company will maintain and preserve for a period of not less than six (6) years from the date an action is taken, the first two (2) years in an easily accessible place, a copy of the information or materials supplied to the Boards of Directors pursuant to this Code of Ethics:
 
 
·
that provided the basis for any amendment or waiver to this Code of Ethics; and
 
 
·
relating to any violation of this Code of Ethics and sanctions imposed for such violation, together with a written record of the approval or action taken by the relevant Board of Directors.
 
Confidentiality
 
All reports and records prepared or maintained pursuant to this Code of Ethics shall be considered confidential and shall be maintained and protected accordingly. Except as otherwise required by law or this Code of Ethics, such matters shall not be disclosed to anyone other than the Independent Directors and their counsel, the Companies and their counsel, the Advisory Group and its counsel and any other advisors, consultants or counsel retained by the Directors, the Independent Directors or any committee of Directors.
 
Amendments
 
This Code of Ethics may not be amended as to any Company except in written form, which is specifically approved by a majority vote of the affected Company’s Directors, including a majority of its Independent Directors.
 
No Rights Created
 
This Code of Ethics is a statement of certain fundamental principles, policies and procedures that govern each of the Senior Officers in the conduct of the Companies’ business. It is not intended to and does not create any rights in any employee, investor, supplier, competitor, shareholder or any other person or entity.
 

Revised: July 30, 2014
 
 
5

 


ACKNOWLEDGMENT FORM
 
I have received and read the Joint Code of Ethics for Chief Executive and Senior Financial Officers, and I understand its contents. I agree to comply fully with the standards contained in the Code of Ethics and the Company’s related policies and procedures. I understand that I have an obligation to report any suspected violations of the Code of Ethics on a timely basis to the Chief Compliance Officer or report it anonymously by following the “whistle blower” policies adopted by the Advisory Group from time to time.
 


   
 
Printed Name
   
   
   
 
Signature
   
   
   
 
Date


Revised: July 30, 2014
6
 
Exhibit (s)
 
 
Powers of Attorney

Each of the undersigned officers and trustees of The Gabelli Go Anywhere Trust, a Delaware statutory trust (the “Fund”), do constitute Agnes Mullady and Andrea Mango as true and lawful attorneys and agents, with full power and authority (acting alone and without the other) to execute in the name and on behalf of each of the undersigned as such officer or trustee, a Registration Statement on Form N-2, including any pre-effective amendments and/or any post-effective amendments thereto and any subsequent Registration Statement of the Fund pursuant to Rule 462(b) of the Securities Act of 1933, as amended (the “1933 Act”), and any other filings in connection therewith, and to file the same under the 1933 Act or the Investment Company Act of 1940, as amended, or otherwise, with respect to the registration of the Fund, and the registration or offering of the Fund’s common shares, par value $0.001 per share (“Common Shares”), Series A Cumulative Puttable and Callable Preferred Shares, par value $0.001 per share (“Preferred Shares”), and Combinations consisting of Common Shares and Preferred Shares; granting to such attorney and agent full power of substitution and revocation in the premises; and ratifying and confirming all that such attorney and agent may do or cause to be done by virtue of these presents.

This Power of Attorney may be executed in multiple counterparts, each of which shall be deemed an original, but which taken together shall constitute one instrument.


IN WITNESS WHEREOF, each of the undersigned has executed this Power of Attorney as of this 23rd day of April 2015.

/s/ Mario J. Gabelli
 
/s/ Anthony S. Colavita
Mario J.  Gabelli
 
Anthony S. Colavita
Trustee, Chairman and Chief Investment Officer
 
Trustee
     
     
/s/ Michael Cosgrove
 
/s/ Frank J. Fahrenkopf, Jr.
Michael Cosgrove
 
Frank J. Fahrenkopf, Jr.
Trustee
 
Trustee
     
     
/s/ Michael J. Melarkey
 
/s/ Kuni Nakamura
Michael J. Melarkey
 
Kuni Nakamura
Trustee
 
Trustee